BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1429427 CN1CCCC1CCc1nc(N2CC3CCC(C2)N3C(=O)OC(C)(C)C)c2cc(Cl)c(c(F)c2n1)-c1cc(O)cc2ccccc12 |TLB:19:18:14.15:11.12.17,(2.92,-4.63,;4.06,-3.6,;5.57,-3.92,;6.34,-2.59,;5.31,-1.44,;3.9,-2.07,;2.57,-1.3,;1.24,-2.07,;-.1,-1.3,;-.1,.24,;-1.43,1.01,;-1.43,2.55,;-.04,3.22,;.3,4.72,;-.66,5.92,;-2.2,5.92,;-3.16,4.72,;-2.82,3.22,;-1.39,5.12,;-1.39,6.66,;-.06,7.43,;-2.72,7.43,;-4.06,6.66,;-5.39,7.43,;-4.06,5.12,;-5.39,5.89,;-2.76,.24,;-4.1,1.01,;-5.43,.24,;-6.77,1.01,;-5.43,-1.3,;-4.1,-2.07,;-4.1,-3.61,;-2.76,-1.3,;-1.43,-2.07,;-6.77,-2.07,;-8.1,-1.3,;-9.43,-2.07,;-10.77,-1.3,;-9.43,-3.61,;-8.1,-4.38,;-8.1,-5.92,;-6.77,-6.69,;-5.43,-5.92,;-5.43,-4.38,;-6.77,-3.61,)| InChI=1S/C36H41ClFN5O3/c1-36(2,3)46-35(45)43-23-11-12-24(43)20-42(19-23)34-28-18-29(37)31(27-17-25(44)16-21-8-5-6-10-26(21)27)32(38)33(28)39-30(40-34)14-13-22-9-7-15-41(22)4/h5-6,8,10,16-18,22-24,44H,7,9,11-15,19-20H2,1-4H3 PRANFVGSKCOXET-UHFFFAOYSA-N 685207 US20240239788, Example 5 RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 17330 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685207&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429620 504486982 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429428 CN(C)CC1(COc2nc(N3C[C@@H]4CC[C@H]3CN4)c3cc(F)c(c(F)c3n2)-c2cc(O)cc3ccccc23)CC1 |r,wD:12.18,15.15,(7.34,-5.78,;7.34,-4.23,;8.67,-3.47,;6,-3.47,;6,-1.93,;4.67,-1.15,;3.33,-1.93,;2,-1.15,;2,.38,;.67,1.15,;.67,2.69,;2,3.47,;2,5,;1.22,4.35,;.14,4.35,;-.67,3.47,;-.67,5,;.67,5.78,;-.67,.38,;-2,1.15,;-3.33,.38,;-4.67,1.15,;-3.33,-1.15,;-2,-1.93,;-2,-3.47,;-.67,-1.15,;.67,-1.93,;-4.67,-1.93,;-4.67,-3.47,;-6,-4.23,;-6,-5.78,;-7.34,-3.47,;-7.34,-1.93,;-8.67,-1.15,;-8.67,.39,;-7.34,1.16,;-6,.39,;-6,-1.15,;7.54,-1.92,;6.77,-.59,)| InChI=1S/C31H33F2N5O2/c1-37(2)16-31(9-10-31)17-40-30-35-28-24(29(36-30)38-15-19-7-8-20(38)14-34-19)13-25(32)26(27(28)33)23-12-21(39)11-18-5-3-4-6-22(18)23/h3-6,11-13,19-20,34,39H,7-10,14-17H2,1-2H3 NQQCYNMKOWECEC-UHFFFAOYSA-N 685208 US20240239788, Example 7::4-(4-((1S,4S)-2,5-diazabicyclo[2.2.2]octan-2-yl)-2-((1- ((dimethylamino)methyl)cyclopropyl)methoxy)-6,8- difluoroquinazolin-7-yl)naphthalen-2-ol RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 2990 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685208 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685208&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 166080661 504486983 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429429 CN(C)C[C@]1(COc2nc(N3CC4CCC3CN4)c3cc(F)c(c(F)c3n2)-c2cc(O)cc3ccccc23)CC1(F)F |r,wU:4.4,wD:4.3,(7.34,-5.78,;7.34,-4.23,;8.67,-3.47,;6,-3.47,;6,-1.93,;4.67,-1.15,;3.33,-1.93,;2,-1.15,;2,.38,;.67,1.15,;.67,2.69,;2,3.47,;2,5,;1.22,4.35,;.14,4.35,;-.67,3.47,;-.67,5,;.67,5.78,;-.67,.38,;-2,1.15,;-3.33,.38,;-4.67,1.15,;-3.33,-1.15,;-2,-1.93,;-2,-3.47,;-.67,-1.15,;.67,-1.93,;-4.67,-1.93,;-4.67,-3.47,;-6,-4.23,;-6,-5.78,;-7.34,-3.47,;-7.34,-1.93,;-8.67,-1.15,;-8.67,.39,;-7.34,1.16,;-6,.39,;-6,-1.15,;6.77,-.59,;7.54,-1.92,;9.08,-1.92,;8.17,-3.33,)| InChI=1S/C31H31F4N5O2/c1-39(2)15-30(14-31(30,34)35)16-42-29-37-27-23(28(38-29)40-13-18-7-8-19(40)12-36-18)11-24(32)25(26(27)33)22-10-20(41)9-17-5-3-4-6-21(17)22/h3-6,9-11,18-19,36,41H,7-8,12-16H2,1-2H3 RHVADVFQUFSHNI-UHFFFAOYSA-N 685210 US20240239788, Example 11a RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 4244 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685210 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685210&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429621 504486985 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429430 COCOc1cc(-c2c(Cl)cc3c(nc(OC[C@]4(CN(C)C)CC4(F)F)nc3c2F)N2CC3CCC(C2)N3)c2ccccc2c1 |r,wU:17.17,wD:17.16,(-9.4,-37.57,;-8.05,-36.79,;-8.05,-35.23,;-9.4,-34.45,;-9.4,-32.89,;-8.05,-32.11,;-8.05,-30.55,;-6.75,-29.78,;-6.75,-28.24,;-8.09,-27.47,;-5.42,-27.47,;-4.08,-28.24,;-2.75,-27.47,;-1.42,-28.24,;-1.42,-29.78,;-.08,-30.55,;1.25,-29.78,;2.58,-30.55,;2.58,-32.09,;3.92,-32.86,;3.92,-34.4,;5.25,-32.09,;3.35,-29.21,;4.12,-30.55,;5.46,-31.32,;5.21,-29.46,;-2.75,-30.55,;-4.08,-29.78,;-5.42,-30.55,;-5.42,-32.09,;-2.75,-25.93,;-4.08,-25.16,;-4.08,-23.62,;-3.4,-24.52,;-2.1,-24.52,;-1.42,-23.62,;-1.42,-25.16,;-2.75,-22.85,;-9.4,-29.77,;-9.42,-28.24,;-10.75,-27.47,;-12.09,-28.24,;-12.09,-29.78,;-10.75,-30.55,;-10.75,-32.11,)| InChI=1S/C33H35ClF3N5O3/c1-41(2)16-32(15-33(32,36)37)17-44-31-39-29-25(30(40-31)42-13-20-8-9-21(14-42)38-20)12-26(34)27(28(29)35)24-11-22(45-18-43-3)10-19-6-4-5-7-23(19)24/h4-7,10-12,20-21,38H,8-9,13-18H2,1-3H3 SZQMIHGUARIJLN-UHFFFAOYSA-N 685215 US20240239788, Example 11b RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 7235 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685215 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685215&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429622 504486990 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429431 OC1CC2CN(CC1N2)c1nc(OCC2(CN3CCOCC3)CC2)nc2c(F)c(c(F)cc12)-c1cc(O)cc2ccccc12 |THB:0:1:8:6.4.5,(3.83,-27.48,;3.73,-29.01,;5.22,-29.41,;3.87,-30.13,;3.29,-31.87,;3.29,-33.41,;1.91,-31.16,;2.36,-29.69,;1.55,-28.17,;3.29,-34.95,;4.62,-35.72,;4.62,-37.26,;5.96,-38.03,;7.29,-37.26,;8.62,-38.03,;7.29,-38.8,;7.29,-40.34,;5.96,-41.11,;5.96,-42.65,;7.29,-43.42,;8.62,-42.65,;8.62,-41.11,;9.96,-38.8,;9.96,-37.26,;3.29,-38.03,;1.95,-37.26,;.62,-38.03,;.62,-39.57,;-.71,-37.26,;-.71,-35.72,;-2.05,-34.95,;.62,-34.95,;1.95,-35.72,;-2.05,-38.03,;-3.38,-37.26,;-4.71,-38.03,;-6.05,-37.26,;-4.71,-39.57,;-3.38,-40.34,;-3.38,-41.88,;-2.05,-42.65,;-.71,-41.88,;-.71,-40.34,;-2.05,-39.57,)| 685217 US20240239788, Example 16 RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 871 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685217&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 171769823 504486992 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429432 OC1CC2CN(CC1N2)c1nc(OCC2(CN3CCOCC3)CC2)nc2c(F)c(c(F)cc12)-c1cc(O)cc2ccccc12 |TLB:9:5:8:1.2,THB:0:1:8:4.6.5,(4.26,7.56,;3.49,6.22,;2.03,6.71,;.62,6.11,;.09,4.67,;1.33,2.34,;1.52,4.15,;2.1,5.58,;-.09,7.67,;1.33,.8,;2.67,.03,;2.67,-1.51,;4,-2.28,;5.33,-1.51,;6.67,-2.28,;5.33,-3.05,;5.33,-4.59,;4,-5.36,;4,-6.9,;5.33,-7.67,;6.67,-6.9,;6.67,-5.36,;8,-3.05,;8,-1.51,;1.33,-2.28,;,-1.51,;-1.33,-2.28,;-1.33,-3.82,;-2.67,-1.51,;-2.67,.03,;-4,.8,;-1.33,.8,;,.03,;-4,-2.28,;-5.33,-1.51,;-6.67,-2.28,;-8,-1.51,;-6.67,-3.82,;-5.33,-4.59,;-5.33,-6.13,;-4,-6.9,;-2.67,-6.13,;-2.67,-4.59,;-4,-3.82,)| 685218 US20240239788, Example 17::(1S,5S,6R)-3-(6,8-difluoro- 7-(3-hydroxynaphthalen-1- yl)-2-((1- (morpholinomethyl)cyclo- propyl)methoxy)quinazolin- 4-yl)-3,8- diazabicyclo[3.2.1]octan-6- ol RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 3263 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685218&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 171769823 504486993 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429433 CN(C)CC1(COc2nc(N3CC4CC(O)[C@H](C3)N4)c3cc(Cl)c(c(F)c3n2)-c2cc(O)cc3ccccc23)CC1 |r,wU:16.18,TLB:15:14:18:11.17.10,9:10:14.13:18,(8.71,-37.18,;8.71,-35.64,;10.04,-34.87,;7.38,-34.87,;7.38,-33.33,;6.04,-32.56,;4.71,-33.33,;3.37,-32.56,;3.37,-31.02,;2.04,-30.25,;2.04,-28.71,;1.21,-26.21,;-.2,-25.59,;-1.6,-26.21,;-2.26,-27.59,;-2.26,-29.13,;-.83,-27.03,;.6,-27.59,;-.83,-24,;.71,-31.02,;-.63,-30.25,;-1.96,-31.02,;-3.29,-30.25,;-1.96,-32.56,;-.63,-33.33,;-.63,-34.87,;.71,-32.56,;2.04,-33.33,;-3.29,-33.33,;-4.63,-32.56,;-5.96,-33.33,;-7.3,-32.56,;-5.96,-34.87,;-4.63,-35.64,;-4.63,-37.18,;-3.29,-37.95,;-1.96,-37.18,;-1.96,-35.64,;-3.29,-34.87,;8.71,-32.56,;7.38,-31.79,)| InChI=1S/C31H33ClFN5O3/c1-37(2)15-31(7-8-31)16-41-30-35-28-22(29(36-30)38-13-18-10-25(40)24(14-38)34-18)12-23(32)26(27(28)33)21-11-19(39)9-17-5-3-4-6-20(17)21/h3-6,9,11-12,18,24-25,34,39-40H,7-8,10,13-16H2,1-2H3 NFSXWVBZXHXQRC-UHFFFAOYSA-N 685219 US20240239788, Example 18a RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 293 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685219 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685219&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429623 504486994 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429434 CN(C)CC1(COc2nc(N3CC4CC(O)[C@@H](C3)N4)c3cc(Cl)c(c(F)c3n2)-c2cc(O)cc3ccccc23)CC1 |r,wD:16.18,TLB:15:14:18:11.17.10,9:10:14.13:18,(8.71,-37.18,;8.71,-35.64,;10.04,-34.87,;7.38,-34.87,;7.38,-33.33,;6.04,-32.56,;4.71,-33.33,;3.37,-32.56,;3.37,-31.02,;2.04,-30.25,;2.04,-28.71,;1.21,-26.21,;-.2,-25.59,;-1.6,-26.21,;-2.26,-27.59,;-2.26,-29.13,;-.83,-27.03,;.6,-27.59,;-.83,-24,;.71,-31.02,;-.63,-30.25,;-1.96,-31.02,;-3.29,-30.25,;-1.96,-32.56,;-.63,-33.33,;-.63,-34.87,;.71,-32.56,;2.04,-33.33,;-3.29,-33.33,;-4.63,-32.56,;-5.96,-33.33,;-7.3,-32.56,;-5.96,-34.87,;-4.63,-35.64,;-4.63,-37.18,;-3.29,-37.95,;-1.96,-37.18,;-1.96,-35.64,;-3.29,-34.87,;8.71,-32.56,;7.38,-31.79,)| InChI=1S/C31H33ClFN5O3/c1-37(2)15-31(7-8-31)16-41-30-35-28-22(29(36-30)38-13-18-10-25(40)24(14-38)34-18)12-23(32)26(27(28)33)21-11-19(39)9-17-5-3-4-6-20(17)21/h3-6,9,11-12,18,24-25,34,39-40H,7-8,10,13-16H2,1-2H3 NFSXWVBZXHXQRC-UHFFFAOYSA-N 685220 US20240239788, Example 18b RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 2678 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685220&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429624 504486995 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429435 CN(C)CC1(COc2nc(N3C[C@@H]4CC[C@@](C)(C3)N4)c3cc(F)c(c(F)c3n2)-c2cc(O)cc3ccccc23)CC1 |r,wD:12.19,15.15,(5.14,-15.5,;6.48,-16.27,;6.48,-17.81,;7.81,-15.5,;7.81,-13.96,;6.48,-13.19,;5.14,-13.96,;3.81,-13.19,;3.81,-11.65,;2.48,-10.88,;2.48,-9.34,;3.81,-8.57,;3.81,-7.03,;3.17,-7.66,;1.78,-7.66,;1.14,-7.03,;-.19,-6.26,;1.14,-8.57,;2.48,-6.26,;1.14,-11.65,;-.19,-10.88,;-1.53,-11.65,;-2.86,-10.88,;-1.53,-13.19,;-.19,-13.96,;-.19,-15.5,;1.14,-13.19,;2.48,-13.96,;-2.86,-13.96,;-4.19,-13.19,;-5.53,-13.96,;-6.86,-13.19,;-5.53,-15.5,;-4.19,-16.27,;-4.19,-17.81,;-2.86,-18.58,;-1.53,-17.81,;-1.53,-16.27,;-2.86,-15.5,;9.35,-13.96,;8.58,-12.63,)| InChI=1S/C32H35F2N5O2/c1-31-9-8-20(37-31)15-39(16-31)29-24-14-25(33)26(23-13-21(40)12-19-6-4-5-7-22(19)23)27(34)28(24)35-30(36-29)41-18-32(10-11-32)17-38(2)3/h4-7,12-14,20,37,40H,8-11,15-18H2,1-3H3 DNJMZBAPSYWRNK-UHFFFAOYSA-N 685222 US20240239788, Example 20 RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 14380 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685222 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685222&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429625 504486997 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429436 CN(C)CC1(COc2nc(N3C[C@H]4CC[C@](C)(C3)N4)c3cc(F)c(c(F)c3n2)-c2cc(O)cc3ccccc23)CC1 |r,wU:12.19,15.15,(5.23,-5.39,;5.23,-3.85,;3.9,-3.08,;6.57,-3.08,;6.57,-1.54,;5.23,-.77,;3.9,-1.54,;2.56,-.77,;2.56,.77,;1.23,1.54,;1.23,3.08,;2.56,3.85,;2.56,5.39,;1.88,4.24,;.62,4.24,;-.1,5.39,;-1.44,6.16,;-.1,3.85,;1.23,6.16,;-.1,.77,;-1.44,1.54,;-2.77,.77,;-4.1,1.54,;-2.77,-.77,;-1.44,-1.54,;-1.44,-3.08,;-.1,-.77,;1.23,-1.54,;-4.1,-1.54,;-5.44,-.77,;-6.77,-1.54,;-8.11,-.77,;-6.77,-3.08,;-5.44,-3.85,;-5.44,-5.39,;-4.1,-6.16,;-2.77,-5.39,;-2.77,-3.85,;-4.1,-3.08,;8.11,-1.54,;7.34,-.21,)| InChI=1S/C32H35F2N5O2/c1-31-9-8-20(37-31)15-39(16-31)29-24-14-25(33)26(23-13-21(40)12-19-6-4-5-7-22(19)23)27(34)28(24)35-30(36-29)41-18-32(10-11-32)17-38(2)3/h4-7,12-14,20,37,40H,8-11,15-18H2,1-3H3 DNJMZBAPSYWRNK-UHFFFAOYSA-N 685223 US20240239788, Example 21::4-(2-((1-((dimethyl- amino)methyl)cyclo- propyl)methoxy)- 6,8-difluoro-4- ((1S,5R)-1-methyl-3,8- diazabicy- clo[3.2.1]octan- 3-yl)quinazolin-7- yl)naphthalen-2-ol RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 1984 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685223 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685223&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429626 504486998 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429437 CN(C)CC1(COc2nc(N3CC4CC(O)C(C3)N4)c3cc(Cl)c(c(F)c3n2)-c2cc(O)cc3ccccc23)CC1 |TLB:9:10:14.13:18,THB:15:14:18:11.17.10,(5.23,-6.21,;5.23,-4.67,;3.9,-3.9,;6.57,-3.9,;6.57,-2.36,;5.23,-1.59,;3.9,-2.36,;2.56,-1.59,;2.56,-.05,;1.23,.72,;1.23,2.26,;2.06,4.78,;3.47,5.39,;4.89,4.77,;5.54,3.38,;7.03,3.78,;4.11,3.94,;2.67,3.39,;4.11,6.98,;-.1,-.05,;-1.44,.72,;-2.77,-.05,;-4.1,.72,;-2.77,-1.59,;-1.44,-2.36,;-1.44,-3.9,;-.1,-1.59,;1.23,-2.36,;-4.1,-2.36,;-5.44,-1.59,;-6.77,-2.36,;-8.11,-1.59,;-6.77,-3.9,;-5.44,-4.67,;-5.44,-6.21,;-4.1,-6.98,;-2.77,-6.21,;-2.77,-4.67,;-4.1,-3.9,;8.11,-2.36,;7.34,-1.03,)| 685224 US20240239788, Example 22b RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 8450 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685224 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685224&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429627 504486999 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429438 COC1CC2CN(CC1N2)c1nc(OCC2(CN(C)C)CC2)nc2c(F)c(c(Cl)cc12)-c1cc(O)cc2ccccc12 |TLB:10:6:3.2:9,THB:1:2:9:7.5.6,(7.55,4.77,;6.22,5.54,;4.89,4.77,;5.54,3.38,;4.11,3.94,;2.67,3.39,;1.23,2.26,;2.06,4.78,;3.47,5.39,;4.11,6.98,;1.23,.72,;2.56,-.05,;2.56,-1.59,;3.9,-2.36,;5.23,-1.59,;6.57,-2.36,;6.57,-3.9,;5.23,-4.67,;5.23,-6.21,;3.9,-3.9,;8.11,-2.36,;7.34,-1.03,;1.23,-2.36,;-.1,-1.59,;-1.44,-2.36,;-1.44,-3.9,;-2.77,-1.59,;-2.77,-.05,;-4.1,.72,;-1.44,.72,;-.1,-.05,;-4.1,-2.36,;-5.44,-1.59,;-6.77,-2.36,;-8.11,-1.59,;-6.77,-3.9,;-5.44,-4.67,;-5.44,-6.21,;-4.1,-6.98,;-2.77,-6.21,;-2.77,-4.67,;-4.1,-3.9,)| 685225 4-(2-((1- ((dimethylamino)meth- yl)cyclopropyl)meth- oxy)-6,8-difluoro-4-(6- methoxy-3,8-di- azabicyclo[3.2.1]octan- 3-yl)quinazolin-7- yl)naphthalen-2-olR,R,::US20240239788, Example 26::US20240239788, Example 24 RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 10800 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685225 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685225&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429628 504487000 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429439 COC1CC2CN(CC1N2)c1nc(OCC2(CN(C)C)CC2)nc2c(F)c(c(F)cc12)-c1cc(O)cc2ccccc12 |TLB:10:6:3.2:9,1:2:9:7.5.6,(5.58,2.19,;4.49,3.28,;4.89,4.77,;5.54,3.38,;4.11,3.94,;2.67,3.39,;1.23,2.26,;2.06,4.78,;3.47,5.39,;4.11,6.98,;1.23,.72,;2.56,-.05,;2.56,-1.59,;3.9,-2.36,;5.23,-1.59,;6.57,-2.36,;6.57,-3.9,;5.23,-4.67,;5.23,-6.21,;3.9,-3.9,;8.11,-2.36,;7.34,-1.03,;1.23,-2.36,;-.1,-1.59,;-1.44,-2.36,;-1.44,-3.9,;-2.77,-1.59,;-2.77,-.05,;-4.1,.72,;-1.44,.72,;-.1,-.05,;-4.1,-2.36,;-5.44,-1.59,;-6.77,-2.36,;-8.11,-1.59,;-6.77,-3.9,;-5.44,-4.67,;-5.44,-6.21,;-4.1,-6.98,;-2.77,-6.21,;-2.77,-4.67,;-4.1,-3.9,)| InChI=1S/C32H35F2N5O3/c1-38(2)16-32(8-9-32)17-42-31-36-29-23(30(37-31)39-14-19-11-26(41-3)25(15-39)35-19)13-24(33)27(28(29)34)22-12-20(40)10-18-6-4-5-7-21(18)22/h4-7,10,12-13,19,25-26,35,40H,8-9,11,14-17H2,1-3H3 CLVFTSLBKXAZFW-UHFFFAOYSA-N 685226 US20240239788, Example 25::4-(2-((1-((dimethyl- amino)methyl)cyclo- propyl)methoxy)-6,8- difluoro-4-(6- methoxy-3,8- diazabicyclo[3.2.1]oc- tan-3-yl)quinazolin- 7-yl)naphthalen-2-ol RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 20270 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685226&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429629 504487001 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429440 COC1CC2CN(CC1N2)c1nc(OCC2(CN(C)C)CC2)nc2c(F)c(c(Cl)cc12)-c1cc(O)cc2ccccc12 |TLB:10:6:3.2:9,THB:1:2:9:7.5.6,(7.55,4.77,;6.22,5.54,;4.89,4.77,;5.54,3.38,;4.11,3.94,;2.67,3.39,;1.23,2.26,;2.06,4.78,;3.47,5.39,;4.11,6.98,;1.23,.72,;2.56,-.05,;2.56,-1.59,;3.9,-2.36,;5.23,-1.59,;6.57,-2.36,;6.57,-3.9,;5.23,-4.67,;5.23,-6.21,;3.9,-3.9,;8.11,-2.36,;7.34,-1.03,;1.23,-2.36,;-.1,-1.59,;-1.44,-2.36,;-1.44,-3.9,;-2.77,-1.59,;-2.77,-.05,;-4.1,.72,;-1.44,.72,;-.1,-.05,;-4.1,-2.36,;-5.44,-1.59,;-6.77,-2.36,;-8.11,-1.59,;-6.77,-3.9,;-5.44,-4.67,;-5.44,-6.21,;-4.1,-6.98,;-2.77,-6.21,;-2.77,-4.67,;-4.1,-3.9,)| 685225 4-(2-((1- ((dimethylamino)meth- yl)cyclopropyl)meth- oxy)-6,8-difluoro-4-(6- methoxy-3,8-di- azabicyclo[3.2.1]octan- 3-yl)quinazolin-7- yl)naphthalen-2-olR,R,::US20240239788, Example 26::US20240239788, Example 24 RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 11790 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685225 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685225&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429628 504487000 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429441 C[C@H]1N[C@H]2CC[C@@H]1N(C2)c1nc(OCC2(CN(C)C)CC2)nc2c(F)c(c(Cl)cc12)-c1cccc2cc(O)ccc12 |r,wU:1.0,wD:3.2,6.7,(-2.67,6.93,;-1.33,6.16,;,6.93,;1.33,6.16,;.55,5.38,;-.55,5.4,;-1.33,4.62,;,3.85,;1.33,4.62,;,2.31,;1.33,1.54,;1.33,,;2.67,-.77,;4,,;5.33,-.77,;5.33,-2.31,;6.67,-3.08,;6.67,-4.62,;8,-2.31,;6.87,-.77,;6.1,.56,;,-.77,;-1.33,,;-2.67,-.77,;-2.67,-2.31,;-4,,;-4,1.54,;-5.33,2.31,;-2.67,2.31,;-1.33,1.54,;-5.33,-.77,;-6.67,,;-8,-.77,;-8,-2.31,;-6.67,-3.08,;-6.67,-4.62,;-5.33,-5.39,;-5.33,-6.93,;-4,-4.62,;-4,-3.08,;-5.33,-2.31,)| InChI=1S/C32H35ClFN5O2/c1-18-26-10-7-20(35-18)15-39(26)30-24-14-25(33)27(23-6-4-5-19-13-21(40)8-9-22(19)23)28(34)29(24)36-31(37-30)41-17-32(11-12-32)16-38(2)3/h4-6,8-9,13-14,18,20,26,35,40H,7,10-12,15-17H2,1-3H3 ZXDRKWXHGAFFJZ-UHFFFAOYSA-N 685229 US20240239788, Example 31::4-(6-chloro-2-((1- ((dimethylamino)meth- yl)cyclopropyl)meth- oxy)-8-fluoro-4- ((1S,4S,6R)-6- methyl-2,5- diazabicyclo [2.2.2]octan-2- yl)quinazolin- 7-yl)naphthalen-2-ol RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 1793 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685229 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685229&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429630 504487003 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429442 CN(C)CC1(COc2nc(N3CC4(C)CCC(C)(C3)N4)c3cc(F)c(c(F)c3n2)-c2cc(O)cc3ccccc23)CC1 |(5.23,-5.39,;5.23,-3.85,;3.9,-3.08,;6.57,-3.08,;6.57,-1.54,;5.23,-.77,;3.9,-1.54,;2.56,-.77,;2.56,.77,;1.23,1.54,;1.23,3.08,;-.1,3.85,;-.1,5.39,;-1.44,6.16,;.92,4.37,;1.54,4.37,;2.56,5.39,;3.9,6.16,;2.56,3.85,;1.23,6.16,;-.1,.77,;-1.44,1.54,;-2.77,.77,;-4.1,1.54,;-2.77,-.77,;-1.44,-1.54,;-1.44,-3.08,;-.1,-.77,;1.23,-1.54,;-4.1,-1.54,;-5.44,-.77,;-6.77,-1.54,;-8.11,-.77,;-6.77,-3.08,;-5.44,-3.85,;-5.44,-5.39,;-4.1,-6.16,;-2.77,-5.39,;-2.77,-3.85,;-4.1,-3.08,;8.11,-1.54,;7.34,-.21,)| InChI=1S/C33H37F2N5O2/c1-31-9-10-32(2,38-31)17-40(16-31)29-24-15-25(34)26(23-14-21(41)13-20-7-5-6-8-22(20)23)27(35)28(24)36-30(37-29)42-19-33(11-12-33)18-39(3)4/h5-8,13-15,38,41H,9-12,16-19H2,1-4H3 ZWXJLPGKSZRSFR-UHFFFAOYSA-N 685231 US20240239788, Example 32 RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 1426 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685231 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685231&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 167216495 504487005 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429443 CCC12CCC(CN(C1)c1nc(OCC3(CN(C)C)CC3)nc3c(F)c(c(F)cc13)-c1cc(O)cc3ccccc13)N2 |(-2.77,5.39,;-1.44,6.16,;-.1,5.39,;.92,4.37,;1.54,4.37,;2.56,5.39,;2.56,3.85,;1.23,3.08,;-.1,3.85,;1.23,1.54,;2.56,.77,;2.56,-.77,;3.9,-1.54,;5.23,-.77,;6.57,-1.54,;6.57,-3.08,;5.23,-3.85,;5.23,-5.39,;3.9,-3.08,;8.11,-1.54,;7.34,-.21,;1.23,-1.54,;-.1,-.77,;-1.44,-1.54,;-1.44,-3.08,;-2.77,-.77,;-2.77,.77,;-4.1,1.54,;-1.44,1.54,;-.1,.77,;-4.1,-1.54,;-5.44,-.77,;-6.77,-1.54,;-8.11,-.77,;-6.77,-3.08,;-5.44,-3.85,;-5.44,-5.39,;-4.1,-6.16,;-2.77,-5.39,;-2.77,-3.85,;-4.1,-3.08,;1.23,6.16,)| InChI=1S/C33H37F2N5O2/c1-4-33-10-9-21(38-33)16-40(18-33)30-25-15-26(34)27(24-14-22(41)13-20-7-5-6-8-23(20)24)28(35)29(25)36-31(37-30)42-19-32(11-12-32)17-39(2)3/h5-8,13-15,21,38,41H,4,9-12,16-19H2,1-3H3 KVVPDPSBEIFRNA-UHFFFAOYSA-N 685232 US20240239788, Example 33::4-(2-((1- ((dimethylamino)meth- yl)cyclopro- pyl)methoxy)-4-(1- ethyl-3,8-diazabicy- clo[3.2.1]octan-3-yl)- 6,8-difluoroquinazolin- 7-yl)naphthalen-2-ol RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 5073 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685232&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 167216493 504487006 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429444 CN(C)CC1(COc2nc(N3CC4CCC(F)(C3)N4)c3cc(Cl)c(c(F)c3n2)-c2cc(O)cc3ccccc23)CC1 |(5.23,-5.39,;5.23,-3.85,;3.9,-3.08,;6.57,-3.08,;6.57,-1.54,;5.23,-.77,;3.9,-1.54,;2.56,-.77,;2.56,.77,;1.23,1.54,;1.23,3.08,;2.56,3.85,;2.56,5.39,;1.54,4.37,;.92,4.37,;-.1,5.39,;-1.44,6.16,;-.1,3.85,;1.23,6.16,;-.1,.77,;-1.44,1.54,;-2.77,.77,;-4.1,1.54,;-2.77,-.77,;-1.44,-1.54,;-1.44,-3.08,;-.1,-.77,;1.23,-1.54,;-4.1,-1.54,;-5.44,-.77,;-6.77,-1.54,;-8.11,-.77,;-6.77,-3.08,;-5.44,-3.85,;-5.44,-5.39,;-4.1,-6.16,;-2.77,-5.39,;-2.77,-3.85,;-4.1,-3.08,;8.11,-1.54,;7.34,-.21,)| InChI=1S/C31H32ClF2N5O2/c1-38(2)15-30(9-10-30)17-41-29-35-27-23(28(36-29)39-14-19-7-8-31(34,16-39)37-19)13-24(32)25(26(27)33)22-12-20(40)11-18-5-3-4-6-21(18)22/h3-6,11-13,19,37,40H,7-10,14-17H2,1-2H3 KZEZOOSLCMEMBA-UHFFFAOYSA-N 685291 US20240239788, Example 34::4-(6-chloro-2-((1- ((dimethylamino)meth- yl)cyclopropyl)meth- oxy)-8-fluoro-4- (1-fluoro-3,8-diaza- bicyclo[3.2.1]octan- 3-yl)quinaozlin-7- yl)naphthalen-2-ol RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 38280 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685291 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685291&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429635 504487065 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429445 CN(C)CC1(COc2nc(N3CC4CC[C@@](C)(C3)N4)c3cc(Cl)c(c(F)c3n2)-c2cc(O)cc3ccccc23)CC1 |r,wU:15.15,(9.17,.24,;8.08,-.85,;8.48,-2.34,;6.59,-.45,;5.5,-1.54,;4.17,-.77,;2.84,-1.54,;1.5,-.77,;1.5,.77,;.17,1.54,;.17,3.08,;-1.17,3.85,;-1.17,5.39,;-.14,4.37,;.48,4.37,;1.5,5.39,;2.84,6.16,;1.5,3.85,;.17,6.16,;-1.17,.77,;-2.5,1.54,;-3.83,.77,;-5.17,1.54,;-3.83,-.77,;-2.5,-1.54,;-2.5,-3.08,;-1.17,-.77,;.17,-1.54,;-5.17,-1.54,;-6.5,-.77,;-7.83,-1.54,;-9.17,-.77,;-7.83,-3.08,;-6.5,-3.85,;-6.5,-5.39,;-5.17,-6.16,;-3.83,-5.39,;-3.83,-3.85,;-5.17,-3.08,;4.73,-2.87,;6.27,-2.87,)| InChI=1S/C32H35ClFN5O2/c1-31-9-8-20(37-31)15-39(16-31)29-24-14-25(33)26(23-13-21(40)12-19-6-4-5-7-22(19)23)27(34)28(24)35-30(36-29)41-18-32(10-11-32)17-38(2)3/h4-7,12-14,20,37,40H,8-11,15-18H2,1-3H3 FDEORNWLZWSPBF-UHFFFAOYSA-N 685292 US20240239788, Example 35::4-(6-chloro-2-((1- ((dimethylamino)meth- yl)cyclopro- pyl)methoxy)- 8-fluoro-4-((1S,5R)-1- methyl-3,8-diaza- bicyclo[3.2.1]octan- 3-yl)quinazolin-7- yl)naphthalen-2-ol RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 1893 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685292 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685292&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429636 504487066 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429446 CN(C)CC1(COc2nc(N3CC4CCC(CC#N)(C3)N4)c3cc(Cl)c(c(F)c3n2)-c2cc(O)cc3ccccc23)CC1 |(5.23,-5.39,;5.23,-3.85,;3.9,-3.08,;6.57,-3.08,;6.57,-1.54,;5.23,-.77,;3.9,-1.54,;2.56,-.77,;2.56,.77,;1.23,1.54,;1.23,3.08,;2.56,3.85,;2.56,5.39,;1.54,4.37,;.92,4.37,;-.1,5.39,;-.69,6.81,;.24,8.03,;1.18,9.26,;-.1,3.85,;1.23,6.16,;-.1,.77,;-1.44,1.54,;-2.77,.77,;-4.1,1.54,;-2.77,-.77,;-1.44,-1.54,;-1.44,-3.08,;-.1,-.77,;1.23,-1.54,;-4.1,-1.54,;-5.44,-.77,;-6.77,-1.54,;-8.11,-.77,;-6.77,-3.08,;-5.44,-3.85,;-5.44,-5.39,;-4.1,-6.16,;-2.77,-5.39,;-2.77,-3.85,;-4.1,-3.08,;8.11,-1.54,;7.34,-.21,)| InChI=1S/C33H34ClFN6O2/c1-40(2)17-32(9-10-32)19-43-31-37-29-25(30(38-31)41-16-21-7-8-33(18-41,39-21)11-12-36)15-26(34)27(28(29)35)24-14-22(42)13-20-5-3-4-6-23(20)24/h3-6,13-15,21,39,42H,7-11,16-19H2,1-2H3 XENFCYDPEKJLGU-UHFFFAOYSA-N 685297 US20240239788, Example 36::2-(3-(6-chloro-2-((1- ((dimethylamino)meth- yl)cyclopro- pyl)methoxy)- 8-fluoro-7-(3-hydroxy- naphthalen-1-yl) quinazolin-4-yl)-3,8- diazabicyclo[3.2.1]oc- tan-1-yl)acetonitrile RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 50000 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685297 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685297&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429637 504487071 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429447 CN(C)CC1(COc2nc(N3C[C@@]4(C)CC[C@H]3CN4)c3cc(Cl)c(c(F)c3n2)-c2cc(O)cc3ccccc23)CC1 |r,wD:16.16,12.12,TLB:9:10:18.17:15.14,(5.23,-5.39,;5.23,-3.85,;3.9,-3.08,;6.57,-3.08,;6.57,-1.54,;5.23,-.77,;3.9,-1.54,;2.56,-.77,;2.56,.77,;1.23,1.54,;1.23,3.08,;2.56,3.85,;2.56,5.39,;3.9,6.16,;1.79,4.06,;.67,5.18,;-.1,3.85,;-.1,5.39,;1.23,6.16,;-.1,.77,;-1.44,1.54,;-2.77,.77,;-4.1,1.54,;-2.77,-.77,;-1.44,-1.54,;-1.44,-3.08,;-.1,-.77,;1.23,-1.54,;-4.1,-1.54,;-5.44,-.77,;-6.77,-1.54,;-8.11,-.77,;-6.77,-3.08,;-5.44,-3.85,;-5.44,-5.39,;-4.1,-6.16,;-2.77,-5.39,;-2.77,-3.85,;-4.1,-3.08,;8.11,-1.54,;7.34,-.21,)| InChI=1S/C32H35ClFN5O2/c1-31-9-8-20(15-35-31)39(16-31)29-24-14-25(33)26(23-13-21(40)12-19-6-4-5-7-22(19)23)27(34)28(24)36-30(37-29)41-18-32(10-11-32)17-38(2)3/h4-7,12-14,20,35,40H,8-11,15-18H2,1-3H3 CKBURMOTKVQOKC-UHFFFAOYSA-N 685298 US20240239788, Example 38a::4-(6-chloro-2-((1- ((dimethylami- no)methyl)cyclopro- pyl)methoxy)- 8-fluoro-4-((1S,4S)- 4-methyl-2,5-diaza- bicyclo[2.2.2]octan- 2-yl)quinazolin-7- yl)naphthalen-2-ol RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 617 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685298 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685298&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429638 504487072 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429448 CC[C@H]1N[C@H]2CC[C@@H]1N(C2)c1nc(OCC2(CN(C)C)CC2)nc2c(F)c(c(Cl)cc12)-c1cc(O)cc2ccccc12 |r,wU:2.1,wD:4.3,7.8,(-1.26,-14.24,;.07,-13.47,;1.4,-14.24,;2.74,-13.47,;4.07,-14.24,;3.55,-15.09,;2.01,-15.09,;1.4,-15.78,;2.74,-16.55,;4.07,-15.78,;2.74,-18.09,;4.07,-18.86,;4.07,-20.4,;5.4,-21.17,;6.74,-20.4,;8.07,-21.17,;8.07,-22.71,;6.74,-23.48,;5.4,-22.71,;6.74,-25.02,;9.61,-21.17,;8.84,-19.83,;2.74,-21.17,;1.4,-20.4,;.07,-21.17,;.07,-22.71,;-1.26,-20.4,;-1.26,-18.86,;-2.6,-18.09,;.07,-18.09,;1.4,-18.86,;-2.6,-21.17,;-3.93,-20.4,;-5.26,-21.17,;-6.6,-20.4,;-5.26,-22.71,;-3.93,-23.48,;-3.93,-25.02,;-2.6,-25.79,;-1.26,-25.02,;-1.26,-23.48,;-2.6,-22.71,)| InChI=1S/C33H37ClFN5O2/c1-4-26-27-10-9-20(36-26)16-40(27)31-24-15-25(34)28(23-14-21(41)13-19-7-5-6-8-22(19)23)29(35)30(24)37-32(38-31)42-18-33(11-12-33)17-39(2)3/h5-8,13-15,20,26-27,36,41H,4,9-12,16-18H2,1-3H3 WAAYFDWCRKNBKZ-UHFFFAOYSA-N 685309 US20240239788, Example 39 RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 4673 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685309 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685309&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429640 504487083 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429449 CN(C)CC1(COc2nc(N3C[C@@H]4C[C@H](O)C(C)(C3)N4)c3cc(Cl)c(c(F)c3n2)-c2cc(O)cc3ccccc23)CC1 |r,wU:12.20,14.14,TLB:9:10:13.14:19,THB:15:14:19:18.11.10,(13.29,-18.42,;11.96,-19.19,;11.96,-20.73,;10.62,-18.42,;9.29,-19.19,;7.96,-18.42,;6.62,-19.19,;5.29,-18.42,;5.29,-16.88,;3.95,-16.11,;3.95,-14.57,;5.39,-13.46,;6.83,-12.89,;8.25,-13.46,;7.6,-12.07,;8.67,-10.96,;6.19,-11.45,;5.09,-10.38,;4.78,-12.07,;6.83,-9.86,;2.62,-16.88,;1.29,-16.11,;-.05,-16.88,;-1.38,-16.11,;-.05,-18.42,;1.29,-19.19,;1.29,-20.73,;2.62,-18.42,;3.95,-19.19,;-1.38,-19.19,;-2.71,-18.42,;-4.05,-19.19,;-5.38,-18.42,;-4.05,-20.73,;-2.71,-21.5,;-2.71,-23.04,;-1.38,-23.81,;-.05,-23.04,;-.05,-21.5,;-1.38,-20.73,;8.52,-20.53,;10.06,-20.53,)| 685311 US20240239788, Example 41 RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 1273 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685311 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685311&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429641 504487085 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429450 CN(C)CC1(COc2nc(N3C[C@H]4NC(C)(C[C@H]4O)C3)c3cc(Cl)c(c(F)c3n2)-c2cc(O)cc3ccccc23)CC1 |r,wU:12.12,17.18,TLB:18:17:13:19.11.10,THB:9:10:17.16:13,(9.34,-1.58,;8,-2.35,;8,-3.89,;6.67,-1.58,;5.33,-2.35,;4,-1.58,;2.67,-2.35,;1.33,-1.58,;1.33,-.04,;,.73,;,2.27,;1.44,3.38,;2.87,3.94,;2.87,6.97,;2.24,5.38,;1.15,6.47,;3.64,4.77,;4.3,3.38,;5.47,4.15,;.83,4.77,;-1.33,-.04,;-2.67,.73,;-4,-.04,;-5.33,.73,;-4,-1.58,;-2.67,-2.35,;-2.67,-3.89,;-1.33,-1.58,;,-2.35,;-5.33,-2.35,;-6.67,-1.58,;-8,-2.35,;-9.34,-1.58,;-8,-3.89,;-6.67,-4.66,;-6.67,-6.2,;-5.33,-6.97,;-4,-6.2,;-4,-4.66,;-5.33,-3.89,;4.56,-3.69,;6.1,-3.69,)| 685316 US20240239788, Example 42::3-(6-chloro-2-((1- ((dimethylamino) methyl)cyclopropyl) methoxy)-8-fluoro-7- (3-hydroxynaphthalen-1- yl)quinazolin-4-yl)-1- methyl-3,8-diazabicyclo [3.2.1]octan-6-ol RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 20450 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685316 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685316&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429642 504487090 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429451 CN(C)CC1(COc2nc(N3CC4C[C@@H](O)[C@@](C)(C3)N4)c3cc(Cl)c(c(F)c3n2)-c2cc(O)cc3ccccc23)CC1 |r,wU:14.14,wD:16.16,TLB:9:10:14.13:19,THB:15:14:19:11.18.10,(9.34,-1.58,;8,-2.35,;8,-3.89,;6.67,-1.58,;5.33,-2.35,;4,-1.58,;2.67,-2.35,;1.33,-1.58,;1.33,-.04,;,.73,;,2.27,;.83,4.77,;2.24,5.38,;3.64,4.77,;4.3,3.38,;5.47,4.15,;2.87,3.94,;3.27,2.46,;1.44,3.38,;2.87,6.97,;-1.33,-.04,;-2.67,.73,;-4,-.04,;-5.33,.73,;-4,-1.58,;-2.67,-2.35,;-2.67,-3.89,;-1.33,-1.58,;,-2.35,;-5.33,-2.35,;-6.67,-1.58,;-8,-2.35,;-9.34,-1.58,;-8,-3.89,;-6.67,-4.66,;-6.67,-6.2,;-5.33,-6.97,;-4,-6.2,;-4,-4.66,;-5.33,-3.89,;4.56,-3.69,;6.1,-3.69,)| 685333 US20240239788, Example 43::3-(6-chloro-2-((1- ((dimethylamino) methyl)cyclopropyl) methoxy)-8-fluoro-7- (3-hydroxynaphthalen-1- yl)quinazolin-4-yl)-5- methyl-3,8-diazabicyclo [3.2.1]octan-6-ol RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 2196 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685333 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685333&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429643 504487107 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429452 CN(C)CC1(COc2nc(N3CC4CCC(C3)N4)c3cc(Cl)c(c(F)c3n2)-c2cc(O)ccc2[Si](C)(C)C)CC1 |(7.24,-19.93,;7.24,-18.48,;5.99,-17.76,;8.49,-17.76,;8.49,-16.22,;7.15,-15.45,;5.82,-16.22,;4.49,-15.45,;4.49,-13.91,;3.15,-13.14,;3.15,-11.6,;1.72,-10.77,;1.72,-9.11,;2.28,-9.86,;3.94,-9.86,;4.59,-9.11,;4.59,-10.77,;3.15,-8.28,;1.82,-13.91,;.49,-13.14,;-.85,-13.91,;-2.18,-13.14,;-.85,-15.45,;.49,-16.22,;.49,-17.76,;1.82,-15.45,;3.15,-16.22,;-2.18,-16.22,;-3.52,-15.45,;-4.85,-16.22,;-6.18,-15.45,;-4.85,-17.76,;-3.52,-18.53,;-2.35,-17.67,;-1.1,-18.39,;.15,-19.11,;-.38,-17.14,;-1.82,-19.64,;10.03,-16.22,;9.26,-14.89,)| InChI=1S/C30H39ClFN5O2Si/c1-36(2)16-30(10-11-30)17-39-29-34-27-22(28(35-29)37-14-18-6-7-19(15-37)33-18)13-23(31)25(26(27)32)21-12-20(38)8-9-24(21)40(3,4)5/h8-9,12-13,18-19,33,38H,6-7,10-11,14-17H2,1-5H3 DTAMBZGFAQDMJT-UHFFFAOYSA-N 685338 US20240239788, Example 45 RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 31640 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685338 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685338&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 171769806 504487112 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429453 Cc1cc(O)cc(c1SC(F)(F)F)-c1c(F)cc2c(nc(OCC3(CN4CCOCC4)CC3)nc2c1F)N1CC2CCC(C1)N2 |(-5.33,-5.01,;-5.33,-3.47,;-6.67,-2.7,;-6.67,-1.16,;-8,-.39,;-5.33,-.39,;-4,-1.16,;-3.95,-2.72,;-2.62,-3.49,;-2.62,-5.03,;-2.62,-6.57,;-4.16,-5.03,;-1.08,-5.03,;-2.67,-.39,;-2.67,1.16,;-4,1.93,;-1.33,1.93,;,1.16,;1.33,1.93,;2.67,1.16,;2.67,-.39,;4,-1.16,;5.33,-.39,;6.67,-1.16,;5.33,-1.93,;5.33,-3.47,;4,-4.24,;4,-5.78,;5.33,-6.55,;6.67,-5.78,;6.67,-4.24,;8,-1.93,;8,-.39,;1.33,-1.16,;,-.39,;-1.33,-1.16,;-1.33,-2.7,;1.33,3.47,;,4.24,;,5.78,;.69,4.59,;2.06,4.59,;2.67,5.78,;2.67,4.24,;1.33,6.55,)| InChI=1S/C31H34F5N5O3S/c1-17-10-20(42)11-21(27(17)45-31(34,35)36)24-23(32)12-22-26(25(24)33)38-29(39-28(22)41-13-18-2-3-19(14-41)37-18)44-16-30(4-5-30)15-40-6-8-43-9-7-40/h10-12,18-19,37,42H,2-9,13-16H2,1H3 NEZNISJOMGWOBT-UHFFFAOYSA-N 685340 US20240239788, Example 49::3-(4-(3,8-diazabicyclo[3.2.1]octan-3- yl)-6,8-difluoro-2-((1- (morpholinomethyl)cyclopropyl)methoxy) quinazolin-7-yl)-5-methyl-4- ((trifluoromethyl)thio)phenol RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 24740 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685340 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685340&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 166080655 504487114 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429454 Nc1ccc2c(F)ccc(-c3c(Cl)cc4c(nc(OCC5(CN6CCOCC6)CC5)nc4c3F)N3CC4CCC(C3)N4)c2n1 |(-6.67,3.47,;-6.67,1.93,;-8,1.16,;-8,-.39,;-6.67,-1.16,;-6.67,-2.7,;-8,-3.47,;-5.33,-3.47,;-4,-2.7,;-4,-1.16,;-2.67,-.39,;-2.67,1.16,;-4,1.93,;-1.33,1.93,;,1.16,;1.33,1.93,;2.67,1.16,;2.67,-.39,;4,-1.16,;5.33,-.39,;6.67,-1.16,;5.33,-1.93,;5.33,-3.47,;4,-4.24,;4,-5.78,;5.33,-6.55,;6.67,-5.78,;6.67,-4.24,;8,-1.93,;8,-.39,;1.33,-1.16,;,-.39,;-1.33,-1.16,;-1.33,-2.7,;1.33,3.47,;,4.24,;,5.78,;.69,4.59,;2.06,4.59,;2.67,5.78,;2.67,4.24,;1.33,6.55,;-5.33,-.39,;-5.33,1.16,)| InChI=1S/C32H34ClF2N7O2/c33-23-13-22-29(27(35)26(23)21-3-5-24(34)20-4-6-25(36)38-28(20)21)39-31(40-30(22)42-14-18-1-2-19(15-42)37-18)44-17-32(7-8-32)16-41-9-11-43-12-10-41/h3-6,13,18-19,37H,1-2,7-12,14-17H2,(H2,36,38) BKNOCEFTZNMWTD-UHFFFAOYSA-N 685341 US20240239788, Example 52::8-(4-(3,8-diazabicyclo[3.2.1]octan-3- yl)-6-chloro-8-fluoro-2-((1- (morpholinomethyl)cyclopropyl)methoxy) quinazolin-7-yl)-5-fluoroquinolin-2- amine RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 3825 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685341 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685341&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 171769768 504487115 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429455 CN(C)CC1(COc2nc(N3CC4CCC(C3)N4)c3cc(Cl)c(c(F)c3n2)-c2cc(O)c(F)c3ccccc23)CC1 |(9.17,.24,;8.08,-.85,;8.48,-2.34,;6.59,-.45,;5.5,-1.54,;4.17,-.77,;2.84,-1.54,;1.5,-.77,;1.5,.77,;.17,1.54,;.17,3.08,;-1.17,3.85,;-1.17,5.39,;-.5,4.2,;.84,4.2,;1.5,5.39,;1.5,3.85,;.17,6.16,;-1.17,.77,;-2.5,1.54,;-3.83,.77,;-5.17,1.54,;-3.83,-.77,;-2.5,-1.54,;-2.5,-3.08,;-1.17,-.77,;.17,-1.54,;-5.17,-1.54,;-6.5,-.77,;-7.83,-1.54,;-9.17,-.77,;-7.83,-3.08,;-9.17,-3.85,;-6.5,-3.85,;-6.5,-5.39,;-5.17,-6.16,;-3.83,-5.39,;-3.83,-3.85,;-5.17,-3.08,;4.73,-2.87,;6.27,-2.87,)| InChI=1S/C31H32ClF2N5O2/c1-38(2)15-31(9-10-31)16-41-30-36-28-22(29(37-30)39-13-17-7-8-18(14-39)35-17)11-23(32)25(27(28)34)21-12-24(40)26(33)20-6-4-3-5-19(20)21/h3-6,11-12,17-18,35,40H,7-10,13-16H2,1-2H3 WYIVAQVJBIZKFU-UHFFFAOYSA-N 685342 US20240239788, Example 57::4-(4-(3,8-diazabicyclo[3.2.1]octan-3- yl)-6-chloro-2-((1- ((dimethylamino)methyl)cyclopropyl) methoxy)-8-fluoroquinazolin-7-yl)-1- fluoronaphthalen-2-ol RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 31530 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685342 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685342&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 171769880 504487116 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429456 CN(C)CC1(COc2nc(N3CC4CCC(C3)N4)c3cc(F)c(c(F)c3n2)-c2c(C)c(Cl)cc3[nH]ncc23)CC1 |(5.23,-5.71,;5.23,-4.17,;3.9,-3.4,;6.57,-3.4,;6.57,-1.86,;5.23,-1.09,;3.9,-1.86,;2.56,-1.09,;2.56,.45,;1.23,1.22,;1.23,2.76,;-.1,3.53,;-.1,5.07,;.56,3.88,;1.9,3.88,;2.56,5.07,;2.56,3.53,;1.23,5.84,;-.1,.45,;-1.44,1.22,;-2.77,.45,;-4.1,1.22,;-2.77,-1.09,;-1.44,-1.86,;-1.44,-3.4,;-.1,-1.09,;1.23,-1.86,;-4.1,-1.86,;-5.44,-1.09,;-5.44,.45,;-6.77,-1.86,;-8.11,-1.09,;-6.77,-3.4,;-5.44,-4.17,;-5.12,-5.68,;-3.59,-5.84,;-2.96,-4.43,;-4.1,-3.4,;8.11,-1.86,;7.34,-.53,)| InChI=1S/C29H32ClF2N7O/c1-15-20(30)9-22-19(10-33-37-22)23(15)24-21(31)8-18-26(25(24)32)35-28(40-14-29(6-7-29)13-38(2)3)36-27(18)39-11-16-4-5-17(12-39)34-16/h8-10,16-17,34H,4-7,11-14H2,1-3H3,(H,33,37) ALEKYYBUJLJVCB-UHFFFAOYSA-N 685344 US20240239788, Example 58::1-(1-(((4-(3,8-diazabicyclo[3.2.1]octan- 3-yl)-7-(6-chloro-5-methyl-1H-indazol- 4-yl)-6,8-difluoroquinazolin-2- yl)oxy)methyl)cyclopropyl)-N,N- dimethylmethanamine RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 45320 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685344 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685344&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 166080656 504487118 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429457 Nc1nc2c(ccc(F)c2s1)-c1c(F)cc2c(nc(OCC3(CN4CC[C@@H](F)C4)CC3)nc2c1F)N1CC2CCC(C1)N2 |r,wD:26.28,(-9.74,3.29,;-8.97,1.96,;-7.44,1.8,;-7.12,.29,;-5.78,-.48,;-5.78,-2.02,;-7.12,-2.79,;-8.45,-2.02,;-9.78,-2.79,;-8.45,-.48,;-9.59,.55,;-4.45,.29,;-4.45,1.83,;-5.78,2.6,;-3.11,2.6,;-1.78,1.83,;-.45,2.6,;.89,1.83,;.89,.29,;2.22,-.48,;3.55,.29,;4.89,-.48,;3.55,-1.25,;3.55,-2.79,;2.31,-3.69,;2.78,-5.16,;4.32,-5.16,;5.23,-6.41,;4.8,-3.69,;6.22,-1.25,;6.22,.29,;-.45,-.48,;-1.78,.29,;-3.11,-.48,;-3.11,-2.02,;-.45,4.14,;-1.88,4.97,;-1.88,6.63,;-1.32,5.89,;.34,5.89,;.99,6.63,;.99,4.97,;-.45,7.46,)| InChI=1S/C30H31F4N7OS/c31-15-5-8-40(10-15)13-30(6-7-30)14-42-29-38-24-19(27(39-29)41-11-16-1-2-17(12-41)36-16)9-21(33)22(23(24)34)18-3-4-20(32)26-25(18)37-28(35)43-26/h3-4,9,15-17,36H,1-2,5-8,10-14H2,(H2,35,37) MAZNYZKVVQPGJC-UHFFFAOYSA-N 685346 US20240239788, Example 61 RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 3350 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685346 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685346&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 167216517 504487120 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429458 Nc1nc2c(ccc(F)c2s1)-c1c(Cl)cc2c(nc(OCC3(CN4CCOCC4)CC3)nc2c1F)N1CC2CCC(C1)N2 |(-7.96,2.62,;-7.19,1.28,;-5.65,1.12,;-5.33,-.38,;-4,-1.16,;-4,-2.7,;-5.33,-3.47,;-6.67,-2.7,;-8,-3.47,;-6.67,-1.16,;-7.81,-.12,;-2.67,-.39,;-2.67,1.15,;-4,1.92,;-1.33,1.92,;,1.15,;1.33,1.92,;2.67,1.15,;2.67,-.39,;4,-1.16,;5.33,-.38,;6.67,-1.15,;5.33,-1.92,;5.33,-3.46,;4,-4.23,;4,-5.77,;5.33,-6.54,;6.67,-5.77,;6.67,-4.23,;8,-.38,;8,-1.92,;1.33,-1.16,;,-.39,;-1.33,-1.16,;-1.33,-2.7,;1.33,3.46,;,4.23,;,5.77,;.84,4.94,;1.93,4.94,;2.67,5.77,;2.67,4.23,;1.33,6.54,)| InChI=1S/C30H32ClF2N7O2S/c31-20-11-19-24(23(33)22(20)18-3-4-21(32)26-25(18)36-28(34)43-26)37-29(38-27(19)40-12-16-1-2-17(13-40)35-16)42-15-30(5-6-30)14-39-7-9-41-10-8-39/h3-4,11,16-17,35H,1-2,5-10,12-15H2,(H2,34,36) HDAMXKVFBHKUOD-UHFFFAOYSA-N 685352 US20240239788, Example 62::4-(4-(3,8-diazabicyclo[3.2.1]octan- 3-yl)-6-chloro-8-fluoro-2-((1- (morpholinomethyl)cyclopropyl) methoxy)quinazolin-7-yl)-7- fluorobenzo[d]thiazol-2-amine RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 334 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685352 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685352&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 166080597 504487126 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429459 CN(C)CC1(COc2nc(N3CC4CCC(C3)N4)c3cc(F)c(c(F)c3n2)-c2c(Cl)c(C)cc3[nH]ncc23)CC1 |(5.14,-5.77,;5.14,-4.23,;3.8,-3.46,;6.47,-3.46,;6.47,-1.92,;5.14,-1.15,;3.8,-1.93,;2.47,-1.15,;2.47,.38,;1.14,1.15,;1.14,2.69,;-.2,3.47,;-.2,5,;.64,4.17,;1.73,4.17,;2.47,5,;2.47,3.47,;1.14,5.78,;-.2,.38,;-1.53,1.15,;-2.87,.38,;-4.2,1.15,;-2.87,-1.15,;-1.53,-1.93,;-1.53,-3.47,;-.2,-1.15,;1.14,-1.93,;-4.2,-1.93,;-4.2,-3.47,;-2.87,-4.23,;-5.53,-4.23,;-5.53,-5.78,;-6.87,-3.47,;-6.87,-1.93,;-8.01,-.89,;-7.38,.51,;-5.85,.35,;-5.53,-1.15,;8.01,-1.92,;7.24,-.59,)| InChI=1S/C29H32ClF2N7O/c1-15-8-21-19(10-33-37-21)22(24(15)30)23-20(31)9-18-26(25(23)32)35-28(40-14-29(6-7-29)13-38(2)3)36-27(18)39-11-16-4-5-17(12-39)34-16/h8-10,16-17,34H,4-7,11-14H2,1-3H3,(H,33,37) NFRJMHKZBCLWAQ-UHFFFAOYSA-N 685356 US20240239788, Example 65::1-(1-(((4-((1R,5S)-3,8- diazabicyclo[3.2.1]octan- 3-yl)-7-(5-chloro-6- methyl-1H-indazol-4-yl)- 6,8-difluoroquinazolin-2- yl)oxy)methyl)cyclopropyl)- N,N-dimethylmethanamine RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 45680 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685356 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685356&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 166080660 504487130 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429460 CN1C[C@H](F)C[C@H]1COc1nc(N2C[C@H]3CC[C@](C)(C2)N3C(=O)OC(C)(C)C)c2cc(F)c(c(F)c2n1)-c1c2C=NCc2cc(C)c1C(F)(F)F |r,wU:14.22,17.18,3.3,wD:6.7,c:44,THB:21:20:19.12.13:16.15,(2.22,-9.19,;3.36,-8.16,;4.87,-8.48,;5.64,-7.15,;7.17,-6.99,;4.61,-6.01,;3.2,-6.63,;1.87,-5.86,;.53,-6.63,;-.8,-5.86,;-.8,-4.32,;-2.13,-3.55,;-2.13,-2.01,;-.7,-1.18,;-.7,.47,;-1.35,-.27,;-3,-.27,;-3.57,.47,;-4.9,1.24,;-3.57,-1.18,;-2.13,1.3,;-2.13,2.84,;-3.47,3.61,;-.8,3.61,;-.8,5.15,;-.8,6.69,;.74,5.15,;-2.34,5.15,;-3.47,-4.32,;-4.8,-3.55,;-6.13,-4.32,;-7.47,-3.55,;-6.13,-5.86,;-4.8,-6.63,;-4.8,-8.17,;-3.47,-5.86,;-2.13,-6.63,;-7.47,-6.63,;-7.47,-8.17,;-6.32,-9.2,;-6.95,-10.61,;-8.48,-10.45,;-8.8,-8.94,;-10.13,-8.17,;-10.13,-6.63,;-11.47,-5.86,;-8.8,-5.86,;-8.8,-4.32,;-8.8,-2.78,;-10.34,-4.32,;-7.26,-4.32,)| 685359 US20240239788, Example 67 RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 4037 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685359 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685359&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429645 504487133 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429461 CN(C)C[C@]1(COc2nc(N3C[C@H]4CC[C@](C)(C3)N4)c3cc(F)c(c(F)c3n2)-c2c(C)c(Cl)cc3[nH]nc(C)c23)CC1(F)F |r,wU:12.19,4.3,15.15,wD:4.4,(3.24,-5.01,;4.57,-4.24,;5.91,-5.01,;4.57,-2.7,;5.91,-1.93,;4.57,-1.16,;3.24,-1.93,;1.91,-1.16,;1.91,.39,;.57,1.16,;.57,2.7,;1.91,3.47,;1.91,5.01,;1.3,3.82,;-.08,3.82,;-.76,5.01,;-2.1,5.78,;-.76,3.47,;.57,5.78,;-.76,.39,;-2.1,1.16,;-3.43,.39,;-4.76,1.16,;-3.43,-1.16,;-2.1,-1.93,;-2.1,-3.47,;-.76,-1.16,;.57,-1.93,;-4.76,-1.93,;-4.76,-3.47,;-3.43,-4.24,;-6.1,-4.24,;-6.1,-5.78,;-7.43,-3.47,;-7.43,-1.93,;-8.57,-.89,;-7.95,.51,;-6.42,.35,;-6.02,1.84,;-6.1,-1.16,;7.24,-2.7,;7.24,-1.16,;7.24,.39,;8.57,-.39,)| InChI=1S/C31H34ClF4N7O/c1-15-19(32)9-21-23(16(2)40-41-21)22(15)24-20(33)8-18-26(25(24)34)37-28(44-14-30(13-42(4)5)11-31(30,35)36)38-27(18)43-10-17-6-7-29(3,12-43)39-17/h8-9,17,39H,6-7,10-14H2,1-5H3,(H,40,41) AJOARTRAKKRVDW-UHFFFAOYSA-N 685383 US20240239788, Example 68::1-((1R)-1-(((7-(6-chloro-3,5-dimethyl-1H- indazol-4-yl)-6,8-difluoro-4-((1S,5R)-1- methyl-3,8-diazabicyclo[3.2.1]octan-3-yl) quinazolin-2-yl)oxy)methyl)-2,2- difluorocyclopropyl)-N,N- dimethylmethanamine RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 3298 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685383 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685383&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429646 504487156 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429462 CN(C)C[C@@]1(COc2nc(N3C[C@H]4CC[C@](C)(C3)N4)c3cc(F)c(c(F)c3n2)-c2cc(O)cc3ccccc23)CC1(F)F |r,wU:12.19,4.3,15.15,wD:4.4,(3.33,-4.62,;4.67,-3.85,;6,-4.62,;4.67,-2.31,;6,-1.54,;4.67,-.77,;3.33,-1.54,;2,-.77,;2,.77,;.67,1.54,;.67,3.08,;2,3.85,;2,5.39,;1.39,4.2,;.02,4.2,;-.67,5.39,;-2,6.16,;-.67,3.85,;.67,6.16,;-.67,.77,;-2,1.54,;-3.33,.77,;-4.67,1.54,;-3.33,-.77,;-2,-1.54,;-2,-3.08,;-.67,-.77,;.67,-1.54,;-4.67,-1.54,;-6,-.77,;-7.34,-1.54,;-8.67,-.77,;-7.34,-3.08,;-6,-3.85,;-6,-5.39,;-4.67,-6.16,;-3.33,-5.39,;-3.33,-3.85,;-4.67,-3.08,;7.34,-.77,;7.34,-2.31,;8.67,-1.54,;8.11,-3.64,)| InChI=1S/C32H33F4N5O2/c1-30-9-8-19(39-30)13-41(15-30)28-23-12-24(33)25(22-11-20(42)10-18-6-4-5-7-21(18)22)26(34)27(23)37-29(38-28)43-17-31(16-40(2)3)14-32(31,35)36/h4-7,10-12,19,39,42H,8-9,13-17H2,1-3H3 WGGDMVGSENMZNE-UHFFFAOYSA-N 685384 US20240239788, Example 69::4-(2-(((R)-1-((dimethylamino)methyl)-2,2- difluorocyclopropyl)methoxy)-6,8-difluoro- 4-((1S,5R)-1-methyl-3,8- diazabicyclo[3.2.1]octan-3-yl)quinazolin- 7-yl)naphthalen-2-ol RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 194 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685384 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685384&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429647 504487157 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429463 CN1C[C@H](F)C[C@H]1COc1nc(N2C[C@H]3CC[C@](C)(C2)N3)c2cc(F)c(c(F)c2n1)-c1cc(O)cc2ccccc12 |r,wU:14.22,3.3,17.18,wD:6.7,(4.05,-3.85,;5.38,-3.08,;6.85,-3.56,;7.75,-2.31,;9.29,-2.31,;6.85,-1.06,;5.38,-1.54,;4.05,-.77,;2.71,-1.54,;1.38,-.77,;1.38,.77,;.05,1.54,;.05,3.08,;1.38,3.85,;1.38,5.39,;.77,4.2,;-.6,4.2,;-1.46,5.51,;-1.98,6.96,;-1.29,3.85,;.05,6.16,;-1.29,.77,;-2.62,1.54,;-3.96,.77,;-5.29,1.54,;-3.96,-.77,;-2.62,-1.54,;-2.62,-3.08,;-1.29,-.77,;.05,-1.54,;-5.29,-1.54,;-6.62,-.77,;-7.96,-1.54,;-9.29,-.77,;-7.96,-3.08,;-6.62,-3.85,;-6.62,-5.39,;-5.29,-6.16,;-3.96,-5.39,;-3.96,-3.85,;-5.29,-3.08,)| InChI=1S/C31H32F3N5O2/c1-31-8-7-19(37-31)14-39(16-31)29-24-12-25(33)26(23-11-21(40)9-17-5-3-4-6-22(17)23)27(34)28(24)35-30(36-29)41-15-20-10-18(32)13-38(20)2/h3-6,9,11-12,18-20,37,40H,7-8,10,13-16H2,1-2H3 KILIVSZBYGIIHM-UHFFFAOYSA-N 685387 US20240239788, Example 70::4-(6,8-difluoro-2-(((2S,4R)-4-fluoro-1- methylpyrrolidin-2-yl)methoxy)-4-((1S,5R)- 1-methyl-3,8-diazabicyclo[3.2.1]octan-3- yl)quinazolin-7-yl)naphthalen-2-ol RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 5386 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685387 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685387&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429648 504487160 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429464 Cc1cc2[nH]ncc2c(-c2c(F)cc3c(nc(OCC4(CN5CCOCC5)CC4)nc3c2F)N2CC3CCC(C2)N3)c1C(F)(F)F |(-5.53,-5.39,;-5.53,-3.85,;-6.87,-3.08,;-6.87,-1.54,;-8.01,-.51,;-7.38,.9,;-5.85,.74,;-5.53,-.77,;-4.2,-1.54,;-2.87,-.77,;-2.87,.77,;-4.2,1.54,;-1.53,1.54,;-.2,.77,;1.14,1.54,;2.47,.77,;2.47,-.77,;3.8,-1.54,;5.14,-.77,;6.47,-1.54,;6.47,-3.08,;5.14,-3.85,;3.8,-3.08,;2.47,-3.85,;2.47,-5.39,;3.8,-6.16,;5.14,-5.39,;8.01,-1.54,;7.24,-.21,;1.14,-1.54,;-.2,-.77,;-1.53,-1.54,;-1.53,-3.08,;1.14,3.08,;-.2,3.85,;-.2,5.39,;.49,4.2,;1.86,4.2,;2.47,5.39,;2.47,3.85,;1.14,6.16,;-4.2,-3.08,;-2.87,-3.85,;-1.53,-4.62,;-2.1,-2.52,;-3.64,-5.18,)| InChI=1S/C32H34F5N7O2/c1-17-10-23-21(12-38-42-23)24(26(17)32(35,36)37)25-22(33)11-20-28(27(25)34)40-30(41-29(20)44-13-18-2-3-19(14-44)39-18)46-16-31(4-5-31)15-43-6-8-45-9-7-43/h10-12,18-19,39H,2-9,13-16H2,1H3,(H,38,42) YPILDUCTVRWLRM-UHFFFAOYSA-N 685396 US20240239788, Example 72::4-((1-(((4-(3,8-diazabicyclo[3.2.1]octan-3-yl)- 6,8-difluoro-7-(6-methyl-5-(trifluoromethyl)- 1H-indazol-4-yl)quinazolin-2- yl)oxy)methyl)cyclopropyl)methyl)morpholine RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 7443 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685396 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685396&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 166080556 504487169 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429465 CN(C)C[C@@]1(COc2nc(N3C[C@H]4CC[C@](C)(C3)N4)c3cc(F)c(c(F)c3n2)-c2c(c(C)cc3[nH]ncc23)C(F)(F)F)CC1(F)F |r,wU:12.19,4.3,15.15,wD:4.4,(3.16,-5.01,;4.5,-4.24,;5.83,-5.01,;4.5,-2.7,;5.83,-1.93,;4.5,-1.16,;3.16,-1.93,;1.83,-1.16,;1.83,.39,;.5,1.16,;.5,2.7,;1.83,3.47,;1.83,5.01,;1.22,3.82,;-.15,3.82,;-1.01,5.12,;-1.53,6.58,;-.84,3.47,;.5,5.78,;-.84,.39,;-2.17,1.16,;-3.51,.39,;-4.84,1.16,;-3.51,-1.16,;-2.17,-1.93,;-2.17,-3.47,;-.84,-1.16,;.5,-1.93,;-4.84,-1.93,;-4.84,-3.47,;-6.17,-4.24,;-6.17,-5.78,;-7.51,-3.47,;-7.51,-1.93,;-8.65,-.89,;-8.03,.51,;-6.49,.35,;-6.17,-1.16,;-3.51,-4.24,;-2.17,-5.01,;-2.74,-2.9,;-4.28,-5.57,;7.16,-1.16,;7.16,-2.7,;8.65,-3.09,;6.77,-4.18,)| InChI=1S/C31H32F7N7O/c1-15-7-20-18(9-39-43-20)21(23(15)31(36,37)38)22-19(32)8-17-25(24(22)33)40-27(46-14-29(13-44(3)4)11-30(29,34)35)41-26(17)45-10-16-5-6-28(2,12-45)42-16/h7-9,16,42H,5-6,10-14H2,1-4H3,(H,39,43) DRLIYGVIVIQGIT-UHFFFAOYSA-N 685397 US20240239788, Example 76a::1-((1R)-1-(((6,8-difluoro-7-(6-methyl-5- (trifluoromethyl)-1H-indazol-4-yl)-4- ((1S,5R)-1-methyl-3,8-diazabicyclo [3.2.1]octan-3-yl)quinazolin-2-yl) oxy)methyl)-2,2-difluorocyclopropyl)- N,N-dimethylmethanamine RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 1813 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685397 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685397&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429649 504487170 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429466 CN(C)C[C@@]1(COc2nc(N3C[C@H]4CC[C@](C)(C3)N4)c3cc(F)c(c(F)c3n2)-c2c(Cl)c(C)cc3[nH]nc(C)c23)CC1(F)F |r,wU:12.19,4.3,15.15,wD:4.4,(3.16,-5,;4.5,-4.24,;5.83,-5,;4.5,-2.7,;5.83,-1.92,;4.5,-1.16,;3.16,-1.92,;1.83,-1.16,;1.83,.38,;.5,1.16,;.5,2.7,;1.83,3.46,;1.83,5,;1.22,3.82,;-.15,3.82,;-1.01,5.12,;-1.53,6.57,;-.84,3.46,;.5,5.78,;-.84,.38,;-2.17,1.16,;-3.51,.38,;-4.84,1.16,;-3.51,-1.16,;-2.17,-1.92,;-2.17,-3.46,;-.84,-1.16,;.5,-1.92,;-4.84,-1.93,;-4.84,-3.47,;-3.51,-4.24,;-6.17,-4.24,;-6.17,-5.78,;-7.51,-3.46,;-7.51,-1.92,;-8.65,-.89,;-8.02,.51,;-6.47,.38,;-5.44,1.53,;-6.17,-1.16,;7.16,-1.16,;7.16,-2.7,;6.77,-4.18,;8.65,-3.09,)| InChI=1S/C31H34ClF4N7O/c1-15-8-20-21(16(2)40-41-20)23(24(15)32)22-19(33)9-18-26(25(22)34)37-28(44-14-30(13-42(4)5)11-31(30,35)36)38-27(18)43-10-17-6-7-29(3,12-43)39-17/h8-9,17,39H,6-7,10-14H2,1-5H3,(H,40,41) ATQVUGQBFDOPGS-UHFFFAOYSA-N 685401 US20240239788, Example 79::1-((1R)-1-(((7-(5-chloro-3,6-dimethyl-1H- indazol-4-yl)-6,8-difluoro-4-((1S,5R)- 1-methyl-3,8-diazabicyclo[3.2.1]octan- 3-yl)quinazolin-2-yl)oxy)methyl)-2,2- difluorocyclopropyl)-N,N- dimethylmethanamine RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 4413 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685401 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685401&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429650 504487174 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429467 Cc1cc2[nH]ncc2c(-c2c(F)cc3c(nc(OCC4(CN5CC[C@@H](F)C5)CC4)nc3c2F)N2C[C@H]3CC[C@](C)(C2)N3)c1C(F)(F)F |r,wU:35.47,38.43,wD:24.25,(-5.43,-4.69,;-5.43,-3.15,;-6.76,-2.38,;-6.76,-.84,;-7.91,.19,;-7.28,1.59,;-5.75,1.43,;-5.43,-.07,;-4.1,-.84,;-2.76,-.07,;-2.76,1.47,;-4.1,2.24,;-1.43,2.24,;-.09,1.47,;1.24,2.24,;2.57,1.47,;2.57,-.07,;3.91,-.84,;5.24,-.07,;6.57,-.84,;5.24,-1.61,;5.24,-3.15,;3.99,-4.06,;4.47,-5.52,;6.01,-5.52,;6.78,-6.86,;6.49,-4.06,;7.91,-1.61,;7.91,-.07,;1.24,-.84,;-.09,-.07,;-1.43,-.84,;-1.43,-2.38,;1.24,3.78,;2.57,4.55,;2.57,6.09,;1.96,4.9,;.59,4.9,;-.27,6.21,;-.79,7.66,;-.09,4.55,;1.24,6.86,;-4.1,-2.38,;-2.76,-3.15,;-1.43,-3.92,;-1.99,-1.82,;-3.53,-4.49,)| InChI=1S/C33H35F6N7O/c1-17-9-23-21(11-40-44-23)24(26(17)33(37,38)39)25-22(35)10-20-28(27(25)36)41-30(42-29(20)46-13-19-3-5-31(2,14-46)43-19)47-16-32(6-7-32)15-45-8-4-18(34)12-45/h9-11,18-19,43H,3-8,12-16H2,1-2H3,(H,40,44) WNQQERKTHBKYEO-UHFFFAOYSA-N 685403 US20240239788, Example 80a::6,8-difluoro-2-((1-(((R)-3-fluoropyrrolidin-1- yl)methyl)cyclopropyl)methoxy)-7- (6-methyl-5-(trifluoromethyl)-1H-indazol- 4-yl)-4-((1S,5R)-1-methyl-3,8- diazabicyclo[3.2.1]octan-3- yl)quinazoline RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 4051 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685403 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685403&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429651 504487176 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429468 C[C@@]12CC[C@H](CN(C1)c1nc(OCC3(CN4CC[C@@H](F)C4)CC3)nc3c(F)c(c(F)cc13)-c1cc(O)cc3ccccc13)N2 |r,wU:4.49,1.0,wD:18.19,(-.69,7.66,;-.17,6.21,;.69,4.9,;2.06,4.9,;2.67,6.09,;2.67,4.55,;1.33,3.78,;,4.55,;1.33,2.24,;2.67,1.47,;2.67,-.07,;4,-.84,;5.33,-.07,;6.67,-.84,;5.33,-1.61,;5.33,-3.15,;4.09,-4.06,;4.56,-5.52,;6.1,-5.52,;6.87,-6.86,;6.58,-4.06,;8,-1.61,;8,-.07,;1.33,-.84,;,-.07,;-1.33,-.84,;-1.33,-2.38,;-2.67,-.07,;-2.67,1.47,;-4,2.24,;-1.33,2.24,;,1.47,;-4,-.84,;-5.33,-.07,;-6.67,-.84,;-8,-.07,;-6.67,-2.38,;-5.33,-3.15,;-5.33,-4.69,;-4,-5.46,;-2.67,-4.69,;-2.67,-3.15,;-4,-2.38,;1.33,6.86,)| InChI=1S/C34H36F3N5O2/c1-33-8-6-22(40-33)16-42(17-33)31-26-14-27(36)28(25-13-23(43)12-20-4-2-3-5-24(20)25)29(37)30(26)38-32(39-31)44-19-34(9-10-34)18-41-11-7-21(35)15-41/h2-5,12-14,21-22,40,43H,6-11,15-19H2,1H3 QMPQIOMQGJMYGU-UHFFFAOYSA-N 685404 US20240239788, Example 81::4-(6,8-difluoro-2-((1-(((R)-3- fluoropyrrolidin-1-yl)methyl)cyclopropyl) methoxy)-4-((1S,5R)-1-methyl-3,8- diazabicyclo[3.2.1]octan-3- yl)quinazolin-7-yl)naphthalen-2-ol RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 1978 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685404 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685404&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429652 504487177 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429469 CN(C)C[C@@]1(COc2nc(N3C[C@H]4CC[C@](C)(C3)N4)c3cc(F)c(c(F)c3n2)-c2c(C)c(C)cc3[nH]ncc23)CC1(F)F |r,wU:12.19,4.3,15.15,wD:4.4,(3.18,-5.01,;4.5,-4.23,;5.85,-5.01,;4.5,-2.69,;5.83,-1.93,;4.5,-1.15,;3.16,-1.93,;1.83,-1.15,;1.83,.39,;.5,1.15,;.5,2.69,;1.83,3.47,;1.83,5.01,;1.2,3.81,;-.18,3.81,;-1.01,5.13,;-1.52,6.58,;-.84,3.47,;.5,5.77,;-.84,.39,;-2.17,1.15,;-3.51,.39,;-4.84,1.15,;-3.51,-1.15,;-2.17,-1.93,;-2.17,-3.47,;-.84,-1.15,;.5,-1.93,;-4.84,-1.92,;-4.84,-3.46,;-3.51,-4.23,;-6.17,-4.23,;-6.17,-5.77,;-7.51,-3.47,;-7.51,-1.93,;-8.65,-.89,;-8.02,.51,;-6.49,.35,;-6.17,-1.15,;7.16,-1.15,;7.16,-2.69,;8.65,-3.09,;6.77,-4.18,)| InChI=1S/C31H35F4N7O/c1-16-8-22-20(10-36-40-22)23(17(16)2)24-21(32)9-19-26(25(24)33)37-28(43-15-30(14-41(4)5)12-31(30,34)35)38-27(19)42-11-18-6-7-29(3,13-42)39-18/h8-10,18,39H,6-7,11-15H2,1-5H3,(H,36,40) IBONVUIPNSJRNP-UHFFFAOYSA-N 685405 US20240239788, Example 82::1-((1R)-1-(((7-(5,6-dimethyl-1H-indazol- 4-yl)-6,8-difluoro-4-((1S,5R)-1-methyl-3,8- diazabicyclo[3.2.1]octan-3-yl)quinazolin-2- yl)oxy)methyl)-2,2-difluorocyclopropyl)- N,N-dimethylmethanamine RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 14750 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685405 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685405&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429653 504487178 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429470 Cc1n[nH]c2cc(Cl)c(C)c(-c3c(F)cc4c(nc(OCC5(CN6CC[C@@H](F)C6)CC5)nc4c3F)N3C[C@H]4CC[C@](C)(C3)N4)c12 |r,wU:37.48,40.44,wD:26.26,(-4.69,2.61,;-5.72,1.46,;-7.28,1.59,;-7.91,.19,;-6.76,-.84,;-6.76,-2.38,;-5.43,-3.15,;-5.43,-4.69,;-4.1,-2.38,;-2.76,-3.15,;-4.1,-.84,;-2.76,-.07,;-2.76,1.47,;-4.1,2.24,;-1.43,2.24,;-.09,1.47,;1.24,2.24,;2.57,1.47,;2.57,-.07,;3.91,-.84,;5.24,-.07,;6.57,-.84,;5.24,-1.61,;5.24,-3.15,;3.99,-4.06,;4.47,-5.52,;6.01,-5.52,;6.78,-6.86,;6.49,-4.06,;7.91,-1.61,;7.91,-.07,;1.24,-.84,;-.09,-.07,;-1.43,-.84,;-1.43,-2.38,;1.24,3.78,;2.57,4.55,;2.57,6.09,;1.96,4.9,;.59,4.9,;-.27,6.21,;-.79,7.66,;-.09,4.55,;1.24,6.86,;-5.43,-.07,)| InChI=1S/C33H37ClF3N7O/c1-17-22(34)11-24-26(18(2)41-42-24)25(17)27-23(36)10-21-29(28(27)37)38-31(39-30(21)44-13-20-4-6-32(3,14-44)40-20)45-16-33(7-8-33)15-43-9-5-19(35)12-43/h10-11,19-20,40H,4-9,12-16H2,1-3H3,(H,41,42) UQRARXIQEJIOOS-UHFFFAOYSA-N 685446 US20240239788, Example 84::7-(6-chloro-3,5-dimethyl-1H-indazol- 4-yl)-6,8-difluoro-2-((1-(((R)-3- fluoropyrrolidin-1-yl)methyl)cyclopropyl) methoxy)-4-((1S,5R)-1-methyl-3,8- diazabicyclo[3.2.1]octan-3- yl)quinazoline RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 9324 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685446 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685446&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429654 504487217 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429471 Cc1n[nH]c2cc(C)c(C)c(-c3c(F)cc4c(nc(OCC5(CN6CC[C@@H](F)C6)CC5)nc4c3F)N3C[C@H]4CC[C@](C)(C3)N4)c12 |r,wU:37.48,40.44,wD:26.26,(-4.69,2.61,;-5.72,1.46,;-7.28,1.59,;-7.91,.19,;-6.76,-.84,;-6.76,-2.38,;-5.43,-3.15,;-5.43,-4.69,;-4.1,-2.38,;-2.76,-3.15,;-4.1,-.84,;-2.76,-.07,;-2.76,1.47,;-4.1,2.24,;-1.43,2.24,;-.09,1.47,;1.24,2.24,;2.57,1.47,;2.57,-.07,;3.91,-.84,;5.24,-.07,;6.57,-.84,;5.24,-1.61,;5.24,-3.15,;3.99,-4.06,;4.47,-5.52,;6.01,-5.52,;6.78,-6.86,;6.49,-4.06,;7.91,-1.61,;7.91,-.07,;1.24,-.84,;-.09,-.07,;-1.43,-.84,;-1.43,-2.38,;1.24,3.78,;2.57,4.55,;2.57,6.09,;1.96,4.9,;.59,4.9,;-.27,6.21,;-.79,7.66,;-.09,4.55,;1.24,6.86,;-5.43,-.07,)| InChI=1S/C34H40F3N7O/c1-18-11-25-27(20(3)41-42-25)26(19(18)2)28-24(36)12-23-30(29(28)37)38-32(39-31(23)44-14-22-5-7-33(4,15-44)40-22)45-17-34(8-9-34)16-43-10-6-21(35)13-43/h11-12,21-22,40H,5-10,13-17H2,1-4H3,(H,41,42) VKVFPTTXTOOEJS-UHFFFAOYSA-N 685447 US20240239788, Example 85::6,8-difluoro-2-((1-(((R)-3-fluoropyrrolidin- 1-yl)methyl)cyclopropyl)methoxy)-4- ((1S,5R)-1-methyl-3,8-diazabicyclo [3.2.1]octan-3-yl)-7-(3,5,6-trimethyl-1H- indazol-4-yl)quinazoline RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 18900 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685447 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685447&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429655 504487218 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429472 Cc1cc2[nH]ncc2c(-c2c(F)cc3c(nc(OC[C@@]45CCCN4C[C@H](F)C5)nc3c2F)N2C[C@H]3CC[C@](C)(C2)N3)c1C(F)(F)F |r,wU:34.46,25.27,37.42,wD:19.19,(-5.95,-5.78,;-5.95,-4.24,;-7.28,-3.47,;-7.28,-1.93,;-8.43,-.89,;-7.8,.51,;-6.27,.35,;-5.95,-1.16,;-4.61,-1.93,;-3.28,-1.16,;-3.28,.39,;-4.61,1.16,;-1.95,1.16,;-.61,.39,;.72,1.16,;2.05,.39,;2.05,-1.16,;3.39,-1.93,;4.72,-1.16,;6.06,-1.93,;5.15,-3.17,;6.06,-4.42,;7.52,-3.94,;7.52,-2.4,;8.43,-1.16,;7.52,.09,;7.92,1.58,;6.06,-.39,;.72,-1.93,;-.61,-1.16,;-1.95,-1.93,;-1.95,-3.47,;.72,2.7,;2.05,3.47,;2.05,5.01,;1.45,3.82,;.07,3.82,;-.79,5.12,;-1.3,6.57,;-.61,3.47,;.72,5.78,;-4.61,-3.47,;-3.28,-4.24,;-1.95,-5.01,;-2.51,-2.9,;-4.05,-5.57,)| InChI=1S/C32H33F6N7O/c1-16-8-22-20(11-39-43-22)23(25(16)32(36,37)38)24-21(34)9-19-27(26(24)35)40-29(46-15-31-5-3-7-45(31)12-17(33)10-31)41-28(19)44-13-18-4-6-30(2,14-44)42-18/h8-9,11,17-18,42H,3-7,10,12-15H2,1-2H3,(H,39,43) VSTJDZKWSGSJHJ-UHFFFAOYSA-N 685448 US20240239788, Example 86::6,8-difluoro-2-(((2R,7aS)-2-fluorotetrahydro- 1H-pyrrolizin-7a(5H)-yl)methoxy)-7- (6-methyl-5-(trifluoromethyl)-1H-indazol- 4-yl)-4-((1S,5R)-1-methyl-3,8-diazabicyclo [3.2.1]octan-3-yl)quinazoline RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 268 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685448 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685448&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429656 504487219 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429473 Cc1cc(N)nc(-c2c(F)cc3c(nc(OCC4(CN5CCOCC5)CC4)nc3c2F)N2CC3CCC(C2)N3)c1C(F)(F)F |(-5.7,.9,;-5.65,2.5,;-7.03,3.36,;-7.03,4.9,;-8.37,5.67,;-5.7,5.67,;-4.37,4.9,;-3.03,5.67,;-3.03,7.21,;-4.37,7.98,;-1.7,7.98,;-.37,7.21,;.97,7.98,;2.3,7.21,;2.3,5.67,;3.64,4.9,;4.97,5.67,;6.3,4.9,;6.3,3.36,;4.97,2.59,;3.72,3.49,;2.32,2.87,;2.16,1.33,;3.4,.43,;4.81,1.06,;7.84,4.9,;7.07,6.23,;.97,4.9,;-.37,5.67,;-1.7,4.9,;-1.7,3.36,;.97,9.52,;-.37,10.29,;-.37,11.83,;.24,10.98,;1.78,10.98,;2.3,11.83,;2.3,10.29,;.97,12.6,;-4.21,3.27,;-2.79,2.51,;-1.38,1.76,;-3.55,1.1,;-2.03,3.93,)| InChI=1S/C30H34F5N7O2/c1-16-10-21(36)38-26(23(16)30(33,34)35)22-20(31)11-19-25(24(22)32)39-28(40-27(19)42-12-17-2-3-18(13-42)37-17)44-15-29(4-5-29)14-41-6-8-43-9-7-41/h10-11,17-18,37H,2-9,12-15H2,1H3,(H2,36,38) LHASOPZQJHAITO-UHFFFAOYSA-N 685449 US20240239788, Example 87 RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 11380 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685449 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685449&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 166080495 504487220 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429474 C[C@@]12CCC(CN(C1)c1nc(OCC34CCCN3C[C@H](F)C4)nc3c(F)c(c(F)cc13)-c1cc(O)cc3cccc(Cl)c13)N2 |r,wU:1.0,19.21,(-1.17,-20.59,;.17,-21.36,;.76,-22.34,;2.3,-22.34,;2.83,-21.36,;2.83,-22.9,;1.5,-23.67,;.17,-22.9,;1.5,-25.21,;2.83,-25.98,;2.83,-27.52,;4.17,-28.29,;5.5,-27.52,;6.83,-28.29,;5.74,-29.37,;6.43,-30.74,;7.95,-30.51,;8.2,-28.99,;9.3,-27.91,;8.61,-26.54,;9.32,-25.17,;7.09,-26.77,;1.5,-28.29,;.17,-27.52,;-1.17,-28.29,;-1.17,-29.83,;-2.5,-27.52,;-2.5,-25.98,;-3.83,-25.21,;-1.17,-25.21,;.17,-25.98,;-3.83,-28.29,;-5.17,-27.52,;-6.5,-28.29,;-7.84,-27.52,;-6.5,-29.83,;-5.17,-30.59,;-5.17,-32.14,;-3.83,-32.9,;-2.5,-32.14,;-2.5,-30.59,;-1.01,-30.99,;-3.83,-29.83,;1.5,-20.59,)| InChI=1S/C33H33ClF3N5O2/c1-32-8-6-20(40-32)15-41(16-32)30-23-12-25(36)27(22-11-21(43)10-18-4-2-5-24(34)26(18)22)28(37)29(23)38-31(39-30)44-17-33-7-3-9-42(33)14-19(35)13-33/h2,4-5,10-12,19-20,40,43H,3,6-9,13-17H2,1H3 HWKPPEBKFGESGK-UHFFFAOYSA-N 685450 US20240239788, Example 89 RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 31.8 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685450 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685450&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429657 504487221 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429475 CN(C)C[C@@]1(COc2nc(N3C[C@H]4CC[C@](C)(C3)N4)c3cc(Cl)c(c(F)c3n2)-c2c(F)cc(F)c3ccc(N)nc23)CC1(F)F |r,wU:12.19,15.15,4.3,wD:4.4,(3.23,-3.47,;4.56,-4.24,;4.56,-5.78,;5.9,-3.47,;5.9,-1.93,;4.56,-1.15,;3.23,-1.93,;1.9,-1.15,;1.9,.39,;.56,1.15,;.56,2.7,;1.9,3.47,;1.9,5.01,;1.21,4.2,;-.05,4.2,;-.77,5.01,;-2.1,5.78,;-.77,3.47,;.56,5.78,;-.77,.39,;-2.1,1.15,;-3.44,.39,;-4.77,1.15,;-3.44,-1.15,;-2.1,-1.93,;-2.1,-3.47,;-.77,-1.15,;.56,-1.93,;-4.77,-1.93,;-4.77,-3.47,;-3.44,-4.24,;-6.1,-4.24,;-7.44,-3.47,;-8.77,-4.24,;-7.44,-1.93,;-8.77,-1.15,;-8.77,.39,;-7.44,1.15,;-7.44,2.7,;-6.1,.39,;-6.1,-1.15,;6.67,-.59,;7.44,-1.93,;8.77,-2.7,;8.53,-.84,)| InChI=1S/C31H31ClF5N7O/c1-29-7-6-15(42-29)10-44(12-29)27-17-8-18(32)22(23-20(34)9-19(33)16-4-5-21(38)39-25(16)23)24(35)26(17)40-28(41-27)45-14-30(13-43(2)3)11-31(30,36)37/h4-5,8-9,15,42H,6-7,10-14H2,1-3H3,(H2,38,39) BQEUBTSCXYWBTR-UHFFFAOYSA-N 685451 US20240239788, Example 92b::8-(6-chloro-2-(((R)-1-((dimethyalmino)methyl)- 2,2-difluorocyclopropyl)methoxy)-8-fluoro-4- ((1S,5R)-1-methyl-3,8-diazabicyclo[3.2.1]octan- 3-yl)quinazolin-7-yl)-5,7-difluoroquinolin-2- amine RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 9211 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685451 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685451&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429658 504487222 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429476 C[C@@]12CC[C@H](CN(C1)c1nc(OCC3(CN4CC[C@@H](F)C4)CC3)nc3CN(CCc13)c1cccc3cccc(Br)c13)N2 |r| InChI=1S/C33H40BrFN6O/c1-32-11-8-24(38-32)17-41(19-32)30-25-10-15-40(28-7-3-5-22-4-2-6-26(34)29(22)28)18-27(25)36-31(37-30)42-21-33(12-13-33)20-39-14-9-23(35)16-39/h2-7,23-24,38H,8-21H2,1H3 BAZYGHIEUSFLLT-UHFFFAOYSA-N 685452 US20240239788, Example 93 RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 35340 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685452 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685452&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429659 504487223 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429477 C[C@]12CC[C@@H](CN(C1)c1nc(OCC3(CN4CC[C@@H](F)C4)CC3)nc3CN(CCc13)c1cccc3cccc(Br)c13)N2 |r| InChI=1S/C33H40BrFN6O/c1-32-11-8-24(38-32)17-41(19-32)30-25-10-15-40(28-7-3-5-22-4-2-6-26(34)29(22)28)18-27(25)36-31(37-30)42-21-33(12-13-33)20-39-14-9-23(35)16-39/h2-7,23-24,38H,8-21H2,1H3 BAZYGHIEUSFLLT-UHFFFAOYSA-N 685453 US20240239788, Example 94::7-(8-bromonaphthalen-1-yl)-2-((1-(((R)-3-fluoropyrroli- din-1-yl)methyl)cyclopropyl)methoxy)-4-((1S,5R)-1- methyl-3,8-diazabicyclo[3.2.1]octan-3-yl)-5,6,7,8- tetrahydropyrido[3,4-d]pyrimidine RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 32920 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685453 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685453&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429660 504487224 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429478 CCOC(=O)c1c(Cl)nc(OCC2(CN3CCOCC3)CC2)nc1N1CC2CCC(C1)N2C(=O)OC(C)(C)C InChI=1S/C27H40ClN5O6/c1-5-37-23(34)20-21(28)29-24(38-17-27(8-9-27)16-31-10-12-36-13-11-31)30-22(20)32-14-18-6-7-19(15-32)33(18)25(35)39-26(2,3)4/h18-19H,5-17H2,1-4H3 IENADHBVGOHCES-UHFFFAOYSA-N 685454 US20240239788, Example 95 RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 15860 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685454 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685454&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 171769665 504487225 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429479 CN(C)C[C@@]1(COc2nc3CC(OC(=O)c3c(n2)N2C[C@H]3CC[C@](C)(C2)N3C(=O)OC(C)(C)C)c2c(c(C)cc3n(ncc23)C2CCCCO2)C(F)(F)F)CC1(F)F |r,THB:27:26:25.18.19:22.21| 685455 US20240239788, Example 96b RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 637 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685455 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685455&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429661 504487226 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429480 COC(=O)c1c(CC(NS(=O)C(C)(C)C)c2c(c(C)cc3n(ncc23)C2CCCCO2)C(F)(F)F)nc(OCC2(CN3CC[C@@H](F)C3)CC2)nc1N1C[C@H]2CC[C@](C)(C1)N2C(=O)OC(C)(C)C |r,THB:60:59:51.52.58:55.54| 685456 US20240239788, Example 98a RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 34160 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685456 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685456&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429662 504487227 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429481 COc1ccc(CNC(=O)NC(=O)c2cnc(Cl)c(F)c2Cl)c(OC)c1 InChI=1S/C16H14Cl2FN3O4/c1-25-9-4-3-8(11(5-9)26-2)6-21-16(24)22-15(23)10-7-20-14(18)13(19)12(10)17/h3-5,7H,6H2,1-2H3,(H2,21,22,23,24) WBIIRSWZQCEIFU-UHFFFAOYSA-N 685457 US20240239788, Example 99 RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 57.5 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685457 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685457&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 171769814 504487228 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429482 CN(C)C[C@@]1(COc2nc(N3C[C@H]4CC[C@](C)(C3)N4)c3cnc(c(F)c3n2)-c2cc(O)cc3cccc(Cl)c23)CC1(F)F |r| InChI=1S/C31H32ClF3N6O2/c1-29-8-7-18(39-29)12-41(14-29)27-21-11-36-25(20-10-19(42)9-17-5-4-6-22(32)23(17)20)24(33)26(21)37-28(38-27)43-16-30(15-40(2)3)13-31(30,34)35/h4-6,9-11,18,39,42H,7-8,12-16H2,1-3H3 HTCBILBIUJQKLI-UHFFFAOYSA-N 685458 US20240239788, Example 100 RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 89.9 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685458 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685458&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429663 504487229 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429483 CN(C)CC1(COc2nc(N3C[C@H]4CC[C@@](C)(C3)N4)c3nnc(cc3n2)-c2cc(O)cc3ccccc23)CC1 |r| InChI=1S/C30H35N7O2/c1-29-9-8-20(33-29)15-37(16-29)27-26-25(31-28(32-27)39-18-30(10-11-30)17-36(2)3)14-24(34-35-26)23-13-21(38)12-19-6-4-5-7-22(19)23/h4-7,12-14,20,33,38H,8-11,15-18H2,1-3H3 MKPWGHIIADBPHV-UHFFFAOYSA-N 685459 US20240239788, Example 101 RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 20930 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685459 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685459&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 166080703 504487230 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429484 C[C@@]12CCC(CN(C1)c1nc(OC[C@@]34CCCN3C[C@H](F)C4)nc3c(F)c(c(F)cc13)-c1nc(O)nc3cccc(C#C)c13)N2 |r,wU:19.21,1.0,wD:13.13,1.1,3.3,(-2.75,-12.42,;-1.42,-13.19,;-.63,-14.11,;.53,-14.11,;1.25,-13.19,;1.25,-14.73,;-.08,-15.5,;-1.42,-14.73,;-.08,-17.04,;1.25,-17.81,;1.25,-19.35,;2.58,-20.12,;3.92,-19.35,;5.25,-20.12,;4,-21.02,;4.48,-22.49,;6.02,-22.49,;6.5,-21.02,;7.74,-20.12,;7.27,-18.65,;8.04,-17.32,;5.73,-18.65,;-.08,-20.12,;-1.42,-19.35,;-2.75,-20.12,;-2.75,-21.66,;-4.09,-19.35,;-4.09,-17.81,;-5.42,-17.04,;-2.75,-17.04,;-1.42,-17.81,;-5.42,-20.12,;-6.75,-19.35,;-8.09,-20.12,;-9.42,-19.35,;-8.09,-21.66,;-6.75,-22.43,;-6.75,-23.97,;-5.42,-24.74,;-4.09,-23.97,;-4.09,-22.43,;-2.6,-22.83,;-1.11,-23.22,;-5.42,-21.66,;-.08,-12.42,)| InChI=1S/C33H32F3N7O2/c1-3-18-6-4-7-23-24(18)28(38-30(44)37-23)25-22(35)12-21-27(26(25)36)39-31(45-17-33-9-5-11-43(33)14-19(34)13-33)40-29(21)42-15-20-8-10-32(2,16-42)41-20/h1,4,6-7,12,19-20,41H,5,8-11,13-17H2,2H3,(H,37,38,44) ARHXOWDEHGDIPR-UHFFFAOYSA-N 683069 US20240216357, Example 12::US20240239788, Example 102::Preparation of (2-(4-(1H-pyrazol-1-yl)phenyl)-6-(2-(((1R,2S)-2-(4-fluorophenyl)cyclopropyl)amino)ethyl)pyri midin-4-yl) (4-(methylsulfonyl)piperazin-1-yl)methanone RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 14.1 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=683069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=683069&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172055969 503272470 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429485 C[C@@]12CC[C@H](CN(C1)c1nc(OCC3(CN4CC[C@@H](F)C4)CC3)nc3c(F)c(c(F)cc13)-c1cc(O)cc3cccc(C#C)c13)N2 |r,wU:4.51,1.0,wD:18.19,(-3.96,6.16,;-2.62,5.39,;-1.95,4.23,;-.61,4.23,;.05,5.39,;.05,3.85,;-1.29,3.08,;-2.62,3.85,;-1.29,1.54,;.05,.77,;.05,-.77,;1.38,-1.54,;2.71,-.77,;4.05,-1.54,;5.38,-.77,;6.71,-1.54,;6.71,-3.08,;8.18,-3.56,;9.08,-2.31,;10.62,-2.31,;8.18,-1.06,;3.28,-2.87,;4.82,-2.87,;-1.29,-1.54,;-2.62,-.77,;-3.96,-1.54,;-3.96,-3.08,;-5.29,-.77,;-5.29,.77,;-6.62,1.54,;-3.96,1.54,;-2.62,.77,;-6.62,-1.54,;-7.96,-.77,;-9.29,-1.54,;-10.62,-.77,;-9.29,-3.08,;-7.96,-3.85,;-7.96,-5.39,;-6.62,-6.16,;-5.29,-5.39,;-5.29,-3.85,;-3.8,-4.25,;-2.31,-4.65,;-6.62,-3.08,;-1.29,6.16,)| InChI=1S/C36H36F3N5O2/c1-3-21-5-4-6-22-13-25(45)14-26(29(21)22)30-28(38)15-27-32(31(30)39)40-34(41-33(27)44-17-24-7-9-35(2,18-44)42-24)46-20-36(10-11-36)19-43-12-8-23(37)16-43/h1,4-6,13-15,23-24,42,45H,7-12,16-20H2,2H3 WWRNTXKWSLTMFN-UHFFFAOYSA-N 685461 US20240239788, Example 103a::4-(6,8-difluoro-2-((1-(((R)-3- fluoropyrrolidin-1- yl)methyl)cyclopropyl)methoxy)-4- ((1S,5R)-1-methyl-3,8- diazabicyclo[3.2.1]octan-3-yl)quinazolin- 7-yl)-5-ethynylnaphthalen-2-ol RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 26.2 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685461 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685461&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429665 504487232 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429486 C[C@]12CC[C@@H](CN1)N(C2)c1nc(OC[C@@]23CCCN2C[C@H](F)C3)nc2c(F)c(c(F)cc12)-c1cc(O)cc2cccc(C#C)c12 |r,wU:4.7,1.0,20.23,wD:14.15,THB:9:7:5.6:2.3,(-1.85,6.16,;-.52,5.39,;.15,4.23,;1.38,5.18,;2.15,3.85,;2.15,5.39,;.82,6.16,;.82,3.08,;-.52,3.85,;.82,1.54,;2.15,.77,;2.15,-.77,;3.48,-1.54,;4.82,-.77,;6.15,-1.54,;5.25,-2.79,;6.15,-4.03,;7.61,-3.56,;7.61,-2.02,;8.52,-.77,;7.61,.48,;8.01,1.96,;6.15,,;.82,-1.54,;-.52,-.77,;-1.85,-1.54,;-1.85,-3.08,;-3.19,-.77,;-3.19,.77,;-4.52,1.54,;-1.85,1.54,;-.52,.77,;-4.52,-1.54,;-5.85,-.77,;-7.19,-1.54,;-8.52,-.77,;-7.19,-3.08,;-5.85,-3.85,;-5.85,-5.39,;-4.52,-6.16,;-3.19,-5.39,;-3.19,-3.85,;-1.7,-4.25,;-.21,-4.65,;-4.52,-3.08,)| 685462 US20240239788, Example 104::4-(6,8-difluoro-2-(((2R,7aS)-2- fluorotetrahydro-1H-pyrrolizin-7a(5H)- yl)methoxy)-4-((1S,4S)-4-methyl-2,5- diazabicyclo[2.2.2]octan-2-yl)quinazolin- 7-yl)-5-ethynylnaphthalen-2-ol RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 5.93 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685462 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685462&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429666 504487233 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429487 CO[C@@H]1C[C@@]2(C)CN(CC1(C)N2)c1nc(OC[C@@]23CCCN2C[C@H](F)C3)nc2c(F)c(c(F)cc12)-c1cc(O)cc2cccc(C#C)c12 |r,wU:23.26,wD:17.18,4.4,2.1,TLB:1:2:11:7.8.6,(4.15,2.31,;2.67,2.71,;2.27,4.2,;.93,4.2,;.26,5.36,;-1.08,6.13,;.26,3.82,;1.59,3.05,;2.92,3.82,;2.92,5.36,;4.26,6.13,;1.59,6.13,;1.59,1.51,;2.92,.74,;2.92,-.8,;4.26,-1.57,;5.59,-.8,;6.93,-1.57,;6.02,-2.82,;6.93,-4.06,;8.39,-3.59,;8.39,-2.05,;9.3,-.8,;8.39,.45,;8.79,1.93,;6.93,-.03,;1.59,-1.57,;.26,-.8,;-1.08,-1.57,;-1.08,-3.11,;-2.41,-.8,;-2.41,.74,;-3.74,1.51,;-1.08,1.51,;.26,.74,;-5.63,-1.67,;-6.72,-.58,;-8.21,-.98,;-9.3,.11,;-8.61,-2.46,;-7.52,-3.55,;-7.91,-5.04,;-6.83,-6.13,;-5.34,-5.73,;-4.94,-4.24,;-3.45,-3.85,;-1.96,-3.45,;-6.03,-3.16,)| InChI=1S/C37H38F3N5O3/c1-5-21-8-6-9-22-12-24(46)13-25(29(21)22)30-27(39)14-26-32(31(30)40)41-34(48-20-37-10-7-11-45(37)17-23(38)15-37)42-33(26)44-18-35(2)16-28(47-4)36(3,19-44)43-35/h1,6,8-9,12-14,23,28,43,46H,7,10-11,15-20H2,2-4H3 DGFLJLNHQOUZEE-UHFFFAOYSA-N 685463 US20240239788, Example 105::4-(6,8-difluoro-2-(((2R,7aS)-2- fluorotetrahydro-1H-pyrrolizin-7a(5H)- yl)methoxy)-4-((1S,5R)-6-methoxy-1,5- dimethyl-3,8-diazabicyclo[3.2.1]octan-3- yl)quinazolin-7-yl)-5-ethynylnaphthalen- 2-ol RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 1030 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685463 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685463&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429667 504487234 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10 1429488 C[C@@]12CC(O)[C@@](C)(CN(C1)c1nc(OC[C@@]34CCCN3C[C@H](F)C4)nc3c(F)c(c(F)cc13)-c1cc(O)cc3cccc(Cl)c13)N2 |r,wU:5.5,21.23,1.0,wD:15.15,TLB:4:3:45:8.7.9,(-1.85,6.16,;-.52,5.39,;.15,4.41,;1.49,4.41,;2.98,4.01,;2.15,5.39,;3.48,6.16,;2.15,3.85,;.82,3.08,;-.52,3.85,;.82,1.54,;2.15,.77,;2.15,-.77,;3.48,-1.54,;4.82,-.77,;6.15,-1.54,;5.25,-2.79,;6.15,-4.03,;7.61,-3.56,;7.61,-2.02,;8.52,-.77,;7.61,.48,;8.01,1.96,;6.15,,;.82,-1.54,;-.52,-.77,;-1.85,-1.54,;-1.85,-3.08,;-3.19,-.77,;-3.19,.77,;-4.52,1.54,;-1.85,1.54,;-.52,.77,;-4.52,-1.54,;-5.85,-.77,;-7.19,-1.54,;-8.52,-.77,;-7.19,-3.08,;-5.85,-3.85,;-5.85,-5.39,;-4.52,-6.16,;-3.19,-5.39,;-3.19,-3.85,;-1.7,-4.25,;-4.52,-3.08,;.82,6.16,)| InChI=1S/C34H35ClF3N5O3/c1-32-13-25(45)33(2,41-32)16-42(15-32)30-22-11-24(37)27(21-10-20(44)9-18-5-3-6-23(35)26(18)21)28(38)29(22)39-31(40-30)46-17-34-7-4-8-43(34)14-19(36)12-34/h3,5-6,9-11,19,25,41,44-45H,4,7-8,12-17H2,1-2H3 CADJZFDNWBXFRT-UHFFFAOYSA-N 685464 US20240239788, Example 106 RAF proto-oncogene serine/threonine-protein kinase [50-132]/GTPase KRas [G12D] Homo sapiens 49.4 US Patent 10.7270/Q2HT2TP6 aid1963997 US20240239788 Sloman, DL; Chessari, G; Schopf, P; Howard, S; Kawai, Y; Shibata, K; Asakura, H; Uno, T; Sagara, T; Nakamura, M; Kobayakawa, Y; Bennett, DJ; Bharathan, I; Graham, TH; Han, Y; Hussain, Z; Ma, X; Mandal, M; Otte, RD; Palani, A; Swaminathan, U; Uehling, M; Ye, Y; Chau, R; Christian, AH; Gathiaka, S; Henderson, TJ; Hennessy, ET; Hoover, AJ; Kawamura, S; Kolaj, I; Lyons, TW; Mitcheltree, MJ; Sather, A 7/18/2024 10/30/2024 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=685464 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=413&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=685464&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase+%5B50-132%5D%2FGTPase+KRas+%5BG12D%5D&column=ki&startPg=0&Increment=50&submit=Search 172429668 504487235 2 VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 9O0V,9O0U,9AYA,9AY7,8GFT,3OMV,8CPD,8CHF,8U1L,9AXC,9AXA,9MMS,9MMR,9MMQ,9MMP,8GAE RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 MTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM 8JHL,7NY8,6YXW,6MQN,7W5R,7C41,7C40,6YR8,5UK9,5UFE,7RSE,7RSC,6W4E,9KFL,4TQ9,5OCG,4DSU,4DST,4DSO,4DSN,6W4F,8G4F,6H47,6H46,5O2T,5O2S,5MLB,5MLA,8QVU,5WPM,5WLB,6P0Z,5VQ0,5VPZ,5VPY,5VPI,5VP7,5V9O,5V9L,5V71,5KYK,6M9W,5WHB,5WHA,9BG5,6GOE,8EPW,8EBZ,7KFZ,6XGV,6OB3,7RP3,8AFC,8X6R,8V3A,8V39,8QUG,8AZX,8AFB,7YCE,7YCC,9E9I GTPase KRas RASK_HUMAN P01116 A8K8Z5 B0LPF9 P01118 Q96D10